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ABSTRACT 
 
 
 
Concerning Brucella LPS: Genetic Analysis and Role in Host-Agent 
Interaction.  (August 2005) 
Joshua Edward Turse, B.S., Bates College 
Chair of Advisory Committee: Dr. Thomas A. Ficht 
 
 
 
Brucella lipopolysaccharide is an important component of virulence in 
brucellosis.  Recent research in macrophage models has shown that Brucella 
LPS does not behave like classical LPS by stimulating potent inflammatory 
responses.  The central hypothesis of this work is that O-antigen is dynamic 
signaling molecular and participates in complex interactions with the host to 
promote productive infection.  A corollary to this is that the host environment is 
dynamic, and Brucella has evolved mechanisms to cope with changing 
environments.  In an effort to understand the contribution of Brucella LPS to 
virulence and pathogenesis, the function of a metabolic locus important in the 
synthesis of LPS has been demonstrated and complemented.  The spontaneous 
loss of LPS expression has been characterized.  Contribution of LPS to 
acquisition of the host environment in tissue culture and mouse models has 
been explored.  This work demonstrated that genes outside the O-antigen 
biosynthesis (manBA) cluster contribute to LPS biosynthesis.  Further high 
 iv 
 
frequency mutation involving manBA is partly responsible for observed 
dissociation of Brucella strains.  Finally, work herein attempts to look at the role 
of LPS in acquisition of the host environment and shows that LPS is important 
for recruiting particular cell populations within a host model of brucellosis. 
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INTRODUCTION AND LITERATURE REVIEW 
 
BACKGROUND 
Taxonomy.  Members of the genus Brucellae are small, non-motile, gram-
negative, non-encapsulated, intracellular zoonotic pathogens that 
opportunistically infect humans.  Phylogenetically, Brucella is grouped with the 
α-Proteobacteria, order Rhizobiales (56).  Related organisms include 
Agrobacterium, Rhizobium, and Bartonella.  Classically, the genus is divided into 
six species, B. abortus, B. suis, B. melitensis, B. neotomae, B. canis, and B. 
ovis.  Brucella abortus and Brucella melitensis are the two most studied of these 
species.  Brucella abortus is the causative agent of infectious bovine abortion, 
Bang’s disease.  Brucella melitensis is an important goat and human pathogen, 
first identified during the Crimean War as causing “Mediterranean gastric 
remittent fever” or Malta fever (19).  There is discussion of the addition of a 
seventh specie to the genus, and whether it should be added as Brucella maris, 
a specie affecting whales or pinnipeds, B. pinnipediae, affecting pinnipeds or B. 
cetaceae, affecting whales (27).  The Brucellae are further discriminated into 
biovars, based upon dye uptake, metabolic processes, such as the ability to 
grow in the absence of carbon dioxide, and susceptibility to phage.  Biovar 1 
This dissertation follows the style of Infection and Immunity. 
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strains are typically used for laboratory research and include the strains focused 
on in this work, Brucella melitensis 16M and Brucella abortus S2308.  
Molecular biology.   Characteristic of Brucellae are two chromosomes of 
1.17 and 2.1 Mb, (102) with the same G + C content and similar proportion of 
potential coding regions (1,138 and 2,059, respectively) (35, 69).  From the 
sequence of Brucella melitensis, several inferences about virulence 
determinants could be made.  Type I, II, and III secretion systems are not 
expressed (2), though genes encoding sec-dependent, sec-independent, and 
flagella-specific type III, type IV, and type V secretion systems as well as 
adhesins, invasins, and hemolysins were identified.  Identification of loci 
encoding essential metabolic and replicative functions is suggestive that both 
genetic elements are chromosomes rather than mega-plasmids (35, 69).   
The disease.  The host range of the genus is broad, comprising dogs, swine, 
sheep, goats, cattle, deer, and humans; producing chronic infection punctuated 
by periods of recurring acute infection.  In humans, the symptoms of brucellosis 
include undulant fever, arthritis and dementia.  Rarely, human cases of 
Brucellosis will progress to meningitis or endocarditis (85, 136).  If left untreated, 
Brucellosis can develop into debilitating chronic infection, resulting in death.  In 
agriculturally important animals, Brucella infection can lead to sterility.  
Pathogenesis.  Common routes of infection include via the conjunctivae, the 
alimentary tract, inhalation and broken skin (122), from contact with 
3 
 
contaminated animals and animal products.  The organism is then spread 
throughout the host by way of the lymphatic system: bacteria are phagocytosed 
by macrophages at the primary site of infection and, transported to regional 
lymph nodes where Brucellae have been shown to persist and multiply within the 
phagolysosomal compartment (8, 24).  The phylogenetic relationship between 
Brucella and the α-subdivision of the Proteobacteriaceae suggests an organism 
capable of quickly adopting changes in response to changing environments.  
Most proteobacteria live in soil; as such must adapt to changing conditions 
present in this environment including reduced nutrient availability.  The ability to 
adapt to nutrient poor conditions is a major contributor to intracellular survival of 
Brucella. 
Threat assessment.  Brucellosis continues to be a major health threat world 
wide among humans and domestic animals.  Human brucellosis has always 
been associated with animal disease (60).  The principal threats to humans are 
B. melitensis, B. suis, and B. abortus.  Incidence and prevalence vary from 
country to country, with small-ruminant brucellosis being the most widespread 
infection.  This is remarkable since eradication programs for bovine brucellosis 
have been largely successful in developed countries (100).  Areas considered to 
have high brucellosis prevalence include the Middle East, countries surrounding 
the Mediterreanean Sea, Southeastern Europe, Sub-Saharan Africa, and South 
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and Central America (including Mexico) (60).  Brucellosis in these areas is 
typically small-ruminant brucellosis, caused by B. melitensis.  
Brucella [suis], weaponized in 1954, was the first biological agent in the 
United States’ arsenal.  Several other countries have been suspected of 
studying the agent as a biological weapon, but to date, no use of Brucella in a 
bioterrorist attack has been reported (67), though there was suspicion of such an 
undertaking in 1999(1).  Since Brucella can be weaponized and delivered by 
aerosol via commonly available equipment (81), there is potential for this 
organism to be deployed as a tactical [battlefield] weapon (60, 67).  In a 
theoretical attack on a population of 100,000 people, 82,500 cases of brucellosis 
requiring extending supportive therapy are predicted, with 413 deaths (82).  In 
1997, the projected economic loss in the case of such an attack was $477.7 
million.  
Brucella virulence factors.  To date, there are two only confirmed virulence 
determinants, the lipopolysaccharide (LPS), which exhibits antigenic and 
dissociation (7), and Type IV secretion system (virB).  Brucellae demonstrate 
antigenic variation in two distinct ways: A versus M epitopes of the O-
polysaccharide and rough versus smooth LPS (12, 41, 42).  Antigenic variation 
may account for the appearance of some Brucella biovars in which A-antigen 
predominates over M-antigen and vice versa.  For example B. abortus biovar 1 
produce predominately A-antigen, while B. abortus biovar 2 produce M-antigen 
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and B. abortus biovar 3 produce roughly equal amounts of both.  One 
component of the LPS that has not been definitively demonstrated is the 
presence of an exopolysaccharide.  Rosinha et al. (125) demonstrated that B. 
abortus strains deficient in the polysaccharide transporter, ExsA, are attenuated 
in mice.  In Rhizobium meliloti, exsA genes are involved in the transport of the 
exopolysaccharide succinoglycan.  Speculation is that exsA mutants in Brucella 
may have altered polysaccharide architecture. 
There is a third antigen that deserves some mention since much literature 
has been devoted to it; native hapten and polysaccharide B were thought to be 
antigenic determinants until Moriyón et al., performed a meticulous study 
comparing outer membranes of B. abortus and B. melitensis (106).  Native 
hapten and polysaccharide B were found to be byproducts of the chemical 
reactions used to analyze Brucella LPS. 
Rough Brucellae are characterized by the lack of O-antigen.  The term 
“rough” is a historical term and is based on observations of colony morphology 
under obliquely reflected light (74).  Henry found that rough colonies were 
yellow-white in color and have a dry, granular appearance, whereas smooth 
colonies are small, round, glistening and blue to blue-green in color.  Some basic 
phenotypic tests include agglutination of roughs by acriflavine and staining of 
rough colonies with crystal violet.  Rough Brucellae are immune to lysis by 
Berkeley phage BK-2.  Rough Brucella abortus, but not Brucella melitensis are 
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susceptible to killing by serum complement (4, 50).  In the host, infection by 
rough Brucella is seemingly inconsequential, since it is cleared at early time 
points.  Yet interest in the use of rough mutants as vaccines persists due to their 
lack of interference with standard diagnostic tests (4, 5, 21, 114, 128, 134, 138). 
Genetics of Brucella O-antigen synthesis.  Brucella O-antigen is required 
for persistence in the host and based on studies with rough derivatives of 
classical smooth strains this survival was thought to originate with increased 
resistance to intracellular killing mechanisms.  However, loss of O-antigen from 
transposon-derived rough mutants revealed little effect on intracellular survival in 
macrophages in several separate studies and in at least one study reportedly 
replicate intracellularly (4, 5, 59, 78, 112, 115).  These data suggest that O-
antigen may play an important role in survival, but one that is different than 
originally predicted.  In order to understand the role of Brucella LPS in survival 
and virulence it is important to know something about its synthesis and structure.  
The nature of the steps leading to the production of Brucella O-antigen are 
not known with certainty, but the following enzymatic functions have been shown 
to be important.  GDP-D-mannose is required for the mannosylation of many 
bacterial cell surface repeat unit polysaccharides and acts as the precursor for 
other nucleotide sugars (GDP--fucose, GDP-colitose, GDP-perosamine and 
GDP--rhamnose) involved in polysaccharide biosynthesis.  Fructose 6-
phosphate feeds a biosynthetic pathway consisting of the following steps: manA, 
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converts fructose 6-phosphate to mannose 6-phosphate; manB, mannose 6-
phosphate to mannose 1-phosphate; manC, mannose 1-phosphate to GDP--
mannose.  Catabolism is not the only method Brucella can use to acquire 
mannose-6-phosphate.  Studies have demonstrated the presence of hexose 
permeases, as well as the ability to grow on a number of carbon sources (47, 
48). 
Phosphomannose isomerase, manA, is responsible for the enzymatic 
conversion of fructose 6-phosphate to mannose 6-phosphate.  ManA is required 
in both the glyocolytic pathway (116) and the pathway leading to O-antigen 
biosynthesis.  ManA has been identified in several enteric bacteria as being 
important to the production of O-antigen, but is not often mapped to 
polysaccharide gene clusters (77), as in Brucella.  
Phosphomannomutase, manB, is responsible for the inter-conversion of 
mannose 6-phosphate to mannose 1-phosphate in the production of precursors 
for LPS.  Much literature from studies of the opportunistic pathogen 
Pseudomonas aeruginosa and the economically important bacterium 
Xanthomonas campestris focus on manB.  In Pseudomonas, the gene encoding 
phosphomannomutase, AlgC (61) is associated with exopolysaccharide and 
lipopolysaccharide virulence determinants.  AlgC deficient Pseudomonads do 
not produce LPS or exopolysaccharide (30, 62).  Knockouts of algC have been 
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shown to be less virulent in mouse models of infection (61, 133), demonstrating 
the importance of phosphomannomutase to LPS biosynthesis and virulence.  
GDP-mannose pyrophosphorylase (GMP), manC (BMEI0344), and transfers 
a guananyl residue to the mannose 1-phosphate synthesized by manB, 
completing synthesis of GDP--mannose.  Phosphomannomutase and GDP-
mannose pyrophosphorylase are thought to participate solely in the production 
of GDP--mannose (77) (FIG. 1).  Other genes implicated in O-antigen 
biosynthesis are identified in Table 1. 
O-antigen dissociation.  The phenomenon of Brucella spontaneous smooth 
to rough transition (dissociation) is well documented (74).  However, the genetic 
basis for these changes (if any) remains undefined.  Alternatively, the 
spontaneous appearance of rough variants could result from a response to 
changing environment and preferential growth in the absence of in vivo selection 
pressure.  As a result, reversion to smooth phenotype may also be explained by 
recognition of changing environmental conditions or reversion of mutants
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FIG. 1. Schematic showing O-antigen biosynthesis steps in Brucella spp. Phosphomannose 
isomerase, manA, is responsible for conversion of fructose 6-phosphate to mannose 6-
phosphate in the Embden-Meyerhof pathway (a).  Phosphomannomutase, manB, is responsible 
for the inter-conversion of mannose 6-phosphate to mannose 1-phosphate in the production of 
precursors for LPS (b).  GDP-mannose pyrophosphorylase (GMP), manC (BMEI0344), transfers 
a guananyl residue to the mannose 1-phosphate from manB, completing synthesis of GDP--
mannose (c).  Phosphomannomutase and GDP-mannose pyrophosphorylase are thought to 
participate solely in the production of GDP--mannose.  The pathway is completed in 
subsequent steps, including elongation of the O-side chain.  Allen et al. demonstrated 
interruption of the phosphomannomutase BMEII0899 (manB) locus by the transposon Tn5 
causes attenuation and shift from smooth LPS (sLPS) to rough LPS (rLPS) (5), (4).  Using similar 
transposon based techniques or allelic exchange with antibiotic resistance markers, additional 
loci (Table 1) have been shown to cause defects in O-antigen synthesis.  
10 
 
 
Table 1.  Summary of genes implicated in rough phenotype. This table was adapted from 
Delrue et al. (33). 
Gene Function B. melitensis ORF 
lpsB, lpcC Mannosyltransferase, Core Biosynthesis 
 
BMEI0509 
wbdA Mannosyltransferase, conversion of GDP--
mannose to mannan, O-chain biosynthesis 
 
BMEI0997 
lpsA Putative glycosyltransferase, O-Antigen polymerase 
(13), O-chain biosynthesis 
 
BMEI1326 
wbpZ O-chain biosynthesis, mannosyltransferase C 
 
BMEI1393 
manB Phosphomannomutase, uses GTP and mannose-6-
phosphate to produce mannose-1-phosphate, O-
chain biosynthesis 
 
BMEI1396 
wbkA Mannosyltransferase, O-chain biosynthesis 
 
BMEI1404 
rfbD GDP-mannose 4,6-dehydratase, converts GDP-
mannose to GDP-4-dehydro-6-deoxy-D-mannose + 
H2O, O-chain biosynthesis 
 
BMEI1413 
perA Perosamine synthetase, converts GDR-4-keto-6-D-
deoxymannose to 4-amino-4,6,dideoxymannose 
(GDP perosamine), O-chain biosynthesis 
 
BMEI1414 
wbpL Putative undecaprenyl-phosphate α-N-
acetylglucosaminyltransferase, catalyzes the 
attachment of the N-actyleglucosamine to the 
undecaprenol carrier for O-chain biosynthesis 
 
BMEI1426 
pgm Phosphoglucomutase converts α-D-glucose 1-
phosphate to α-D-glucose 6-phosphate, O-chain 
biosynthesis 
 
BMEI1886 
manB, pmm Phosphomannomutase converts α-D-mannose-6-
phosphate to α-D-mannose-1-phosphate, O-chain 
biosynthesis. 
 
BMEII0899 
manA, wbpW, 
pmi 
Phosphomannose isomerase converts α-D-
mannose-1-phosphate to GDP-mannose O-chain 
biosynthesis 
BMEII0900 
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(primary or secondary sites) to smooth character.  For example, the former 
vaccine strain 45/20 is a spontaneously appearing rough strain, derived from B. 
abortus 45 after 20 in vitro passages.  The cause of the rough phenotype of 
45/20 is unknown, however, its reversion to virulent smooth form resulted in its 
discontinued use as a vaccine strain shortly after introduction (129).  In contrast, 
RB51, a current vaccine strain, is also a natural attenuated rough mutant of B. 
abortus S2308 that contains a transposon (IS711) insertion in the wboA gene, 
encoding glycosyltransferase (139).  Reversion to smooth phenotype has not 
been reported for RB51 and the insertion in wboA appears to be one of several 
defects resulting in the rough phenotype (138, 139). 
Mechanisms responsible for dissociation may include the activity of 
transposases, recombinases, resolvases, and integrases to facilitate illegitimate 
recombination.  Analysis of the B. melitensis genome indicates 41 transposases 
(35).  Transposases are typically encoded by the transposon they facilitate.  The 
transposase recognizes the cognate element (particular sequences are 
recognized by different transposon families), breaks the DNA and inserting the 
transposon (116).  To date, only one transposon-like element has been 
demonstrated in Brucella (71); tn2020 is 815bp.  Recently, with the completion 
of the B. abortus genomic sequence, deletion events that may be important for 
speciation have become apparent (69).  Similar events could be responsible for 
the loss of O-antigen expression. 
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Recombinases catalyze strand exchanges between specific DNA sequences, 
and can be broken into two categories, resolvases and invertases.  No 
recombinases have been demonstrated in Brucella, but a BLAST search with the 
B. melitensis genome suggests several may be present.  For our purposes, the 
most interesting may be the invertases, since they are well characterized in the 
Salmonellae (Hin, Gin, Pin, Cin) (94).  Brucella possesses several palindromic 
repeat elements, which form stem loop structures within themselves (70).  One 
could postulate that two of these repeat elements in close proximity could form a 
larger stem loop structure, essentially deleting the intervening structure by 
“looping out” (tandem repeat deletions) (17).  Authors T. Ficht and C. Allen 
appear to suggest this possibility in their 1998 publication on transposon derived 
rough mutants, wherein they identify a Bru-RS1-like repeat near the manBA 
locus in B. abortus (5).  The situation at manBA almost directly reflects that in 
Salmonella at the H2 locus.  The H2 locus possesses an upstream element, the 
H segment that is flanked by two inverted repeats.  Inversion of the H segment 
between the inverted repeats controls the expression at H2.  Resolvases are 
another class of recombinase that shows homology to the Hin, Gin, Pin, and Cin 
invertases (14).  They are mainly associated with transposons. 
Other possibilities for genomic modifications exist; for example, Brucellae 
also possess the insertion elements IS711 (71), or IS6501 (110), about 900bp in 
length.  IS6501/711 has been speculated to encode a transposase, similar to a 
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transposases found in Mycobacteria.  A genomic island containing several 
insertion sequences was identified as containing the O-antigen coding genes of 
Brucella (26, 58).  Most attention around Brucella insertion sequences has 
focused on IS6501/711, since it may contribute to the attenuation of the current 
vaccine strain, RB51 (137, 139).  
Integrases are typically associated with phage, though horizontal transfer 
from phage to Brucella could conceivably introduce integrases to the genome.  
Integrases recognizes a specific site in DNA, and integrate viral DNA into the 
genome of the viral host.  In their analysis of the B. melitensis genome, Del 
Vechhio et al., identified 16 ORFs related to phage on chromosome I. 
Detailing modes of chromosomal rearrangement would not be complete 
without mentioning two other organisms.  Prokaryotes are not known to exhibit 
programmed changes to their DNA.  Two notable exceptions are the 
cyanobacteria Anabaena 7120, which excises two nitrogen fixation elements 
during heterocyst formation (63) and Bacillus subtilis, which excises 42kb from 
the sigK gene during sporulation.  (88).  Rearrangement of the nitrogen fixation 
gene in Anabaena is mediated by transposase-like elements, xisA and xisC as 
part of the programmed rearrangement cyanobacteria undergo in heterocyst 
formation.  XisA was characterized by transposon and site directed 
mutagenesis, while xisC has only been characterized by its homology to xisA. 
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Mutation of Gram-negative bacteria from smooth to rough phenotype may be 
the result of random events or a response to changing environments.  Brucella 
may need to be rough in order to adapt the host as a suitable environment.  In 
the paradigm learned from enteric bacteria, an antigenic switch from smooth 
LPS to rough LPS would cause the host to switch from an inflammatory 
response, TH1, to TH2 response, during which IL-10 would be released.  IL-10 
functions to down-regulate TH1 responses and inhibits cytokine release, 
increasing the chances for colonization of the host.  These rough organisms 
would almost certainly be susceptible to killing, but having served the purpose of 
modulating the host immune response, chronic infection with the surviving 
smooth Brucellae could be established.  
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SPECIFIC AIMS 
 
This research focuses on the initial interactions between Brucella and the 
target cells that control the host’s innate immune response.  O-antigen produces 
the majority of antibody response Brucella, highlighting intimate processing of 
LPS by host cells.  Recent observations demonstrate significant differences in 
the host response to smooth and rough Brucella (21, 112, 121), suggesting an 
important signaling role for O-antigen during these initial interactions.  Ultimately, 
these tentative exchanges may control survival of Brucella, but the exact 
mechanism(s) remains undefined.  The work proposed explores the contribution 
of O-antigen in establishing a productive infection.  The central hypothesis of this 
work is that O-antigen restricts macrophage activation and promotes productive 
infection.  A corollary to this is that the host environment is dynamic, and 
Brucella has evolved mechanisms to cope with changing environments.  To 
explore this hypothesis, these aims are proposed: 
 
A.1 Demonstrate, definitively, the link between manBA expression and 
LPS biosynthesis. 
 
A.2 Determine the rate of appearance of spontaneous, rough isolates 
and identify genetic changes associated with their appearance. 
 
A.3 Evaluate the role of Brucella LPS in uptake and survival of the 
organism through comparison of survival of smooth and rough 
variants in vitro and in vivo. 
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ManBA (BMEII0899-0900) IS ESSENTIAL FOR LPS BIOSYNTHESIS 
 
INTRODUCTION 
The lipopolysaccharide of Brucella is a classical gram negative LPS in form 
only: it is a tripartite structure consisting of lipid A, core oligosaccharide and O-
antigen.  At the molecular level and with respect to activity it is clearly non-
classical.  Compared to enterobacterial LPS, Brucella LPS contains only amide 
bonds as opposed to the typical amide and ester bonds, Brucella Lipid-A is a 
diaminoglucose rather than glucosamine, and the acylation of the Lipid A is 
much greater (C18-19, C28, rather than C12 and 14)(91).  The activity of 
Brucella LPS is much lower than enterobacterial LPS’ (23, 104, 119).  O-antigen 
produces the primary antibody response in the host.  In Brucella abortus, the O-
antigen consists of a homopolymer of 4,6-dideoxy-4-formamido-D-
mannopyranose (N-formyl perosamine) linked in an α-1,2 fashion (A antigen), 
while the N-formyl perosamine homopolymer found in Brucella melitensis 
consists of 4 residues linked in an α-1,2 fashion with a fifth in an α-1,3 fashion 
(91, 101, 104, 106) (FIG. 2). 
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The decreased activity of Brucella LPS can be correlated with an increased 
acylation state of the lipid A moiety (46, 66, 80).  Lipid A interacts with host cells 
primarily through TLR-4.  Altering the pattern of lipid A on the surface of the 
bacterium changes the dynamic between the TLR-4 receptor and the pathogen 
(83). 
The phosphomannomutase/phosphomannose isomerase locus (manBA) has 
been implicated as being important for the production of LPS in models that use 
a transposon to interrupt the gene.  Allen et al. and Monreal et al. studied 
transposon mutants of B. abortus (4, 5, 103) while Foulonge et al. characterized 
manBA transposon mutants in B. suis (53).  The goal of this study was to knock 
out manBA, complement the loss of activity.  This will definitively demonstrate 
the role of manBA in the production of Brucella LPS in B. abortus and B. 
melitensis.  In these models, LPS has been shown to play an important role in 
resistance to complement-mediated killing, survival in macrophage models and 
animal models.  Based on these studies, our hypothesis is that manBA 
(BMEII0899-900) is important for LPS biosynthesis. 
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FIG. 2. Molecular schematic of A- and M-antigen.  Found in the lipopolysaccharide of Brucella 
abortus and Brucella melitensis, respectively.  Brucella O-antigen is a homopolymer of 4-
formamido-4,6-dideoxymannose (N-formyl perosamine), repeating approximately 100 residues.  
In B. abortus, the homopolymer is linked predominantly in an -1,2 fashion, while B. melitensis N-
formyl perosamine is four units linked in -1,2 with a fifth unit linked -1,3.  This heterologous 
linkage in M-Antigen is displayed in red.  
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MATERIALS AND METHODS 
Bacteria, plasmids, growth conditions and restriction endonucleases.  
All bacteria and plasmids used during the course of this investigation are 
listed in Table 2.  All of the restriction endonucleases used in this study were 
purchased from Roche Biochemicals, with the exception of Asc I, which was 
purchased from New England Biolabs.  FastStart Taq was purchased from 
Roche Biochemicals.  AccuTaq LA was purchased from Sigma Chemicals.  T4 
DNA Ligase was purchased from Promega.  
Virulent B. abortus S2308 (B. Deyoe, NADC) and B. melitensis 16M (ATCC), 
were re-isolated from aborted fetuses of cattle or goats, respectively.  Brucella 
strains used in this study, or their derivatives were grown on tryptic soy agar 
(TSA, Difco Laboratories, Detroit, MI) medium with appropriate antibiotics, 
except where noted.  Liquid cultures of Brucella were grown in tryptic soy broth 
(TSB, Difco Laboratories, Detroit, MI) or SOC-B [6% (w/v) trypticase soy broth, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose](89).  
E. coli DH10B, DH5a, β2155, bacterial cultures were routinely diluted in either 
peptone saline [1% Bacto peptone (w/v), 0.5% NaCl (w/v/)], or phosphate 
buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM 
KH2PO4 ).  All Brucella cultures were inactivated by autoclaving or heat killing in 
phenol saline [0.05% (v/v) phenol/0.85% (w/v) NaCl] at 65°C for a minimum of 2 
hours.  E. coli cultures were incubated on Luria-Bertani (LB, Difco Laboratories) 
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Table 2. List of bacterial strains and plasmids used in this study. 
Strain/Plasmid Relevant Markers Source 
B. abortus   
S2308 
B. abortus wild-type isolate, type strain (biovar 
1) Lab stock, bovine isolate 
S2308∆manBA S2308 ∆manBA::KmR This study 
B. melitensis   
16M 
 
B. melitensis wild-type isolate, type strain 
(biovar 1) Lab stock, goat isolate 
16M∆manBA 
 
16M ∆manBA::KmR This study 
E. coli   
DH10B 
 
F- mcrA ∆(mrr-hsdRMS-mcrBC) 80lacZ∆M15 
∆lacX74 recA1 endA1 ara∆139 ∆(ara-
leu)7697 galU galK rpsL nupG Invitrogen 
TOP10 
 
F- mcrA ∆(mrr-hsdRMS-mcrBC) 80lacZ∆M15 
∆lacX74 recA1 ara139 ∆(ara-leu)7697 galU 
galK rpsL endA1 nupG Invitrogen 
DH5α 
 
F- 80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 
endA1 hsdR17(rk-, mk+) phoA supE44 - thi-1 
gyrA96 relA1 Invitrogen 
β2155 
 
ThrB1004 pro thi strA hsdS lacZDM15 (F’ 
lacZ∆M15 lacIq trajD36 proA1 proB1) 
∆dapA::erm (ErmR) pir::RP4 (::kan (KmR) from 
SM10) Dehio et al.(32) 
pBBR1MCS6-y 
 
Cloning vector, CmR, GFP P. Elzer (107) 
pBluescript KS 
II(+) 
 
Cloning vector Stratagene 
pKD4 
 
Source of nptII cassette and FRT sites B. Wanner (31) 
pJET1445 
 
B. melitensis manBA operon in pBBR1MCS6-
y, CmR This study 
pJET931MA 
 
pBluescript containing manBA 3’ and 5’ 
fragments, used to construct pJET940MA, 
AmpR This study 
pJET940MA 
 
Suicide vector for deletion of manBA, KanR, 
AmpR This study 
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plates for 18 hours with appropriate antibiotics.  When appropriate, antibiotics 
were added to the following final concentrations: kanamycin, 100 µg/ml; 
chloramphenicol, 30µg/ml and ampicillin, 100 µg/ml. Unless otherwise noted, all 
bacterial strains were grown at 37°C, 5% (v/v) CO2. 
Molecular biology, polymerase chain reaction, and primers.  Genetic 
manipulations were carried out using standard techniques (127).  Primers used 
in this study can be found in Table 3.  All primer design was performed using 
Accelrys MacVector™.   
DNA was digested with selected restriction endonucleases using 1U of 
enzyme per microgram DNA.  Ligations were performed in a total volume of 
20µl, containing 2µl 10X ligase buffer, 6U of T4 ligase and 3:1 molar ratios of 
insert:vector DNA.  Total DNA was between 150-500ng.  Ligation mixtures were 
incubated at 14°C for 18 hours before transformation.  Typical PCR reactions 
contained reaction mixture contained 50-200ng target DNA, 0.5µM of each 
primer, 200µM of each deoxyribonucleoside triphosphate, 2U of FastStart Taq 
polymerase, 1x PCR buffer, 2mM MgCl2.  As necessary, PCR products and 
digested vectors were gel purified and extracted using the QIAGEN QIAEXII gel 
purification kit. 
Southern blotting is a routine technique and was used for examining the 
presence or absence of genes in total genomic DNA.  
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Table 3. List of primers used in this study 
Primer Sequence Purpose 
TAF204 GGCGCGCCACGTCTTGAGCGATTGTGTAGG 
TAF205 GGCGCGCCGGACAACAAGCCAGGGATGTAAC 
nptII amplification 
 
 
TAF234 GCTCTCCATGATTTCGGGTA 
TAF235 CGCTTCGCAAAATTGAAAAT 
Amplification of 
nylC 
 
 
TAF251 CGGGATCCCGGCAAAGGGTTCCGCAATAC 
TAF254 GGCAAAATACCGGCGCGCCGCAAATCCCTGCCGACAAAC 
5’ manBA 
fragment 
 
 
TAF252 CGGGATCCCGGGTCAGTCATCAGTTGCGGATTC 
TAF253 GCAGGGATTTGCGGCGCGCCGGTATTTTGCCCCTCGTCCTG 
3’ manBA 
fragment 
 
 
TAF419 TTCCAGGCAGATACAGG 
TAF420 ATCCCAATAGGCCGAATGCCAA 
Amplification of 
manBA 
 
TAF433 GAAGATCTTCCAGGCAGATACAGG 
TAF434 GAGATCTATCCCAATAGGCCGAATGCCAA 
manBA 
expression 
construct 
 
 
 
Production of hybrid PCR products.  Hybrid PCR products were produced 
in order to construct an allelic exchange knockout vector.  Primers were 
designed to amplify regions of DNA flanking the 5’ and 3’ ends of manBA.  
Specifically, the reverse primer of the 5’ region and forward primer of the 3’ 
region have been designed to contain complementary sequences, with an 
engineered restriction site.  Products from this PCR reaction were diluted 1:100 
and used as template in a subsequent reaction to create a hybrid PCR product, 
consisting of the 5’ product and 3’ product, joined.  This hybrid product contains 
a restriction site in the center that was exploited to clone in a selectable marker 
(FIG. 3).  
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Transformation and selection of recombinant plasmids.  Following 
ligations, 20 µl of cells (TOP10, DH5α, or DH10B) were mixed with a 1µl portion 
of the ligation mixture and kept on ice for 30 minutes.  Samples were heat 
shocked at 42°C for 1 minute, then immediately placed on ice for 2 minutes.  
Two hundred and fifty microliters of SOC [6% (w/v) trypticase soy broth (w/v), 
10mM NaCl, 2.5mM KCl, 10mM MgCl2 and 20mM glucose] were added to the 
samples, which were then incubated at 37°C with agitation for one hour.  
Samples were plated on plates containing appropriate antibiotics and screened 
the following day by preparing mini-preparations of plasmid DNA followed by 
digestion with restriction endonucleases to map the product.  Recombinant 
plasmids in E. coli hosts are frozen in 50% peptone saline/glycerol and stored at 
-80°C. 
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5' Product 3' Product
Genomic DNA Contatining Gene of Interest
Gene Of Interest
Step 1
Step 2
A
5' Product 3' Product
D
Restriction endonuclease site
Hybrid PCR product
5' Product 3' Product
 
FIG. 3. Production of hybrid PCR products.  In the first round of amplification, regions flanking 
the gene of interest are amplified.  In this cartoon, the 5’ product is AB and the 3’ product is CD.  
In the second round of amplification, product AB and product CD are used as the template, with 
the forward primer for product AB and the reverse primer for product CD.  The result is  a hybrid 
PCR product that joins AB and CD.  Wavy lines signify restriction endonulcease recognition sites 
that were introduced during primer design. 
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Transformation and selection of Brucella mutants.  The knockout vector 
was delivered to virulent B. abortus S2308 and B. melitensis16M via 
electroporation.  Strains were grown for electroporation by one of two methods.  
In the first approach, Brucella was grown from the frozen stocks on tryptic soy 
agar to confluence for 72 hours at 37°C.  Bacteria were re-suspended by 
scraping off the plate into 5 ml of PBS.  The resulting suspensions, containing 
approximately 5 x 1011 CFU/ml, were transferred from the plate into a 50ml 
conical tube.   
Alternatively, isolated colonies were selected following 72 hours of growth 
and used to inoculate 5 ml of fresh TSB.  These cultures were grown for 48 
hours to achieve saturation.  Fifty microliters of the saturated culture was used to 
inoculate 10 ml of fresh TSB.  Cultures were incubated at 37°C for 18 hours, 
achieving a density of approximately 2x109 CFU/ml.   
Once the bacterial suspensions were prepared, they were pelleted by 
centrifugation at 3800g x 15 minutes in a Jouan CR 4.12 preparative centrifuge 
equipped with a M4 swinging bucket rotor.  From this point forward, all reagents 
were kept at 4°C.  The supernatant was removed and the pellet was washed 
three times with 50ml ice-cold molecular biology grade water (Mediatech, 
Herndon, VA).  After the final wash, the pellet was re-suspended in 1 ml of ice-
cold molecular biology grade water.  Two microliters of RNA-free plasmid (~0.1-
0.3 µg) was added to 70 µl washed cells in a sterile microfuge tube.  This 
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mixture was stirred with a pipet tip and placed in a chilled electroporation cuvette 
with a 1 mm gap (VWR, West Chester, PA).  Current was applied from a BTX 
600 electroporation generator set to 265 ohms, 25 µF, 2.5 kV (BTX, Holliston, 
MA) in a BL3 biological safety cabinet.  One milliliter of SOC-B was used to 
remove cells from the cuvette to a sterile microfuge tube.  Cells were allowed to 
recover at 37°C, with shaking, 6 to 18 hours.  After the recovery period, 
electroporants were plated on TSA with appropriate antibiotics.  Colonies arose 
between 3-8 days and were screened by various techniques.  Knockouts were 
confirmed by PCR analysis and Southern blotting. 
Transformation of Brucella strains by conjugation.  Brucellae were 
incubated on TSA for 72 hours to achieve confluence.  The donor E. coli strain 
β2155, was incubated on plates containing appropriate antibiotics and 50µg/ml 
diaminopimelic acid (DAP) for 24 hours.  To prepare the conjugations, both 
strains, donor and recipient, were harvested from plates in approximately 2 ml 
peptone saline with DAP.  The bacterial suspensions were pelleted for 2 minutes 
x 12,000G in a microfuge.  The pellets were re-suspended in 100µl of peptone 
saline containing 50µg/ml DAP.  The bacterial suspensions were combined and 
applied to NC20 nitrocellulose filters (Schleicher and  Schuell, Dassel, Germany) 
on a TSA plates containing 50µg/ml DAP.  Mating was allowed to occur over a 
2-hour period, after which the filter was harvested, placed in a microfuge tube, 
and the bacteria washed off with 1 ml peptone saline without DAP.  Conjugants 
27 
 
were recovered by plating the entire suspension TSA with appropriate 
antibiotics.  Screening of conjugants was performed by crystal violet staining (6).  
Molecular detection of LPS.  Five milliliters of TSB with appropriate 
antibiotics were inoculated with Brucella.  After the culture reached saturation, 
48-72 hours, the bacteria were killed by the combination of heat and exposure to 
phenol.  Cultures were pelleted at 3800g x 15 minutes in a Jouan CR 4.12 
preparative centrifuge equipped with a M4 swinging bucket rotor.  The pellets 
were re-suspended in phenol saline and incubated in a 65° water bath for 18 
hours.  The heat killed Brucella were pelleted and washed with PBS to remove 
residual phenol saline as previously described.  After the final wash, pellets were 
re-suspended in PBS to achieve an optical density of 0.8 at a wavelength of 
420nm.  One and one-half milliliter of this suspension was pelleted at 13,000g x 
2 minutes in a microfuge using a fixed angle rotor.  The supernatant was 
aspirated.  Fifty microliters of PBS, pH 7.2, was used to re-suspend the pellet; 
50 µl of 2x Laemmli sample buffer was added to the suspension.  Samples were 
heated at 100 °C for 15 min, allowed to cool, spun briefly in a microfuge.  A 
volume of 15µl of each sample was loaded onto an SDS-PAGE gel.  The gel 
was electrophoresed at 200V until the dye front reached the bottom edge of the 
gel.  Characterization of LPS occurred using one of the two following methods: 
In the first method, fluorescent labeling of LPS was performed directly in 
polyacrylamide gels, utilizing the fluorescent hydrazide, Pro-Q Emerald 300 dye.  
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This dye can be conjugated to glycoproteins.  The reaction generates a highly 
fluorescent conjugate that can be visualized easily (132), using a standard gel 
documentation setup for agarose gels, with UV transilluminator, as described by 
the manufacturer, Molecular Probes. 
For the second method, Brucella LPS was visualized by Western blotting 
utilizing antibody to Brucella LPS.  The electrophoresed lysates were transferred 
to a PVDF membrane (Immobilon-P, Millipore) using a semi-dry procedure.  The 
stacking gel was removed from the polyacrylamide gel containing the 
electrophoresed samples.  The gel was equilibrated in cathode buffer [25 mM 
Tris, 20% (v/v) methanol, 40 mM 6-amino-N-hexanoic acid, pH not adjusted] for 
10 minutes.  The transfer membrane was soaked in absolute methanol for 10 
seconds, and then moved to anode buffer 2 [25 mM Tris, 20% (v/v) methanol, 
pH 10.4] for 5 minutes.  Simultaneously, wicks were prepared by soaking two 
pieces of filter paper (3mm Whatman Chromatography Paper) in anode buffer 1 
[300 mM Tris, 20% (v/v) methanol, pH 10.4], one piece of filter paper in anode 
buffer 2, and three pieces of filter paper in cathode buffer.  The proportions of 
each component of the transfer stack were the same as the polyacrylamide gel.  
The transfer stack was assembled on the anode plate of a semi-dry transfer cell 
(Owl Separation Systems, Portsmouth, NH), placing the two pieces of filter 
paper soaked in anode buffer 1, followed by the piece of filter paper soaked in 
anode buffer 2, the transfer membrane, the gel, the three pieces of filter paper 
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soaked in cathode buffer, and finally the cathode plate.  Protein was transferred 
to the transfer membrane using constant current of 2 mA/cm2 of gel area for one 
hour. 
Unbound sites on the membrane were blocked by incubation for 30 minutes 
in PBS with 3% (w/v) bovine serum albumin (SIGMA, cat# A7030).  The 
membrane was washed in PBS containing 0.05% (v/v) Tween-20 (PBS-T).  
Depending on the species, the whole blot was incubated 2 hours to overnight in 
either sensitized anti-Brucella melitensis goat sera (diluted 1:200 in PBS-T) or 
anti-Brucella  abortus LPS mouse monoclonal antibody 39 (diluted 1:200 in PBS-
T, kindly provided by Dr. L.G. Adams).  After being washed in 3 times in PBS-T, 
the blot was incubated 2 hours to overnight with a secondary antibody, either 
1:5000 rabbit anti-goat or 1:2000 goat anti-mouse, conjugated to alkaline 
phosphatase.  The secondary antibody was removed and the blots were washed 
2x in PBS, 1x in molecular biology grade water.  Signal was visualized by 
reaction with NBT-BCIP solution prepared according to manufacturer 
instructions (Roche Biochemicals).  The alkaline phosphatase reaction was 
stopped by the addition of TE (10mM Tris, 1mM EDTA, pH 8.0). 
Phenotypic confirmation of rough mutants.  The rough phenotype of 
selected mutants was confirmed by acriflavine agglutination (6).  Ten microliters 
of bacteria from an 18-24 hour liquid culture, was spotted onto a glass slide.  
30 
 
This sample was mixed with 10µl of a 0.1% (wt/vol) aqueous solution of 
acriflavine.  Agglutination is consistent with a rough phenotype (6). 
Complement mediated killing.  Fresh serum was collected from goat, cow 
and human donors for use in these experiments.  Complement mediated killing 
was measured as per Corbeil et al. (29) Bacteria were incubated for 24 hours on 
solid media as appropriate for the strains being tested.  The bacteria were 
harvested tryptone-phosphate buffer, pH 8.0 [25mM Na2HPO4, 25mM NaH2PO4, 
0.1% tryptone (w/v)].  The cell concentration was adjusted to a reading of 0.125 
at OD610 (2 x 109 cfu/ml).  Bacteria were diluted 1:10 with tryptose-phosphate 
buffer.  50µl of dilute bacteria were added to 50µl of fresh, undiluted serum in the 
wells of a microdilution plate.  Control assays included heat inactivated sera.  
Mixtures were incubated for 4 hours at 37°.   
RESULTS 
Targeting of manBA for deletion by allelic exchange.  Primers suitable 
for this study were designed with the aid of Accelrys MacVector™.  Amplification 
of nptII from pKD4 was performed using primers TAF204 and TAF205, each of 
which contains an AscI restriction endonuclease recognition site to facilitate 
cloning.  The 5’ and 3’ manBA knockout products were amplified using primer 
pairs TAF251/TAF254 and TAF252/TAF253 respectively.  Primers TAF251 and 
TAF253 contain a BamHI restriction endonuclease recognition sequence to 
facilitate cloning.  Primers TAF254 and TAF252 contain complementary regions 
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consisting of an AscI restriction endonuclease recognition site to both facilitate 
cloning of the nptII cassette and cross-priming of PCR products to produce a 
hybrid product.  The reaction mixture contained 1µl B. melitensis crude extract 
DNA from a lyzozyme/proteinase K digestion, 0.5µM of each primer, 200µM of 
each deoxyribonucleoside triphosphate, 2U of FastStart Taq polymerase, 1x 
PCR buffer, 2mM MgCl2. Amplification of the hybrid product was achieved using 
a reaction mixture containing 1µl of 1:100 fold diluted PCR product for the 5’ and 
3’ regions. 
Construction of manBA knockout vector.  A vector that is non-replicative 
in Brucella was constructed to knockout manBA (FIG. 4).  A hybrid PCR product 
consisting of the 5’ and 3’ regions flanking manBA was cloned into the BamHI 
restriction endonuclease site of pBluescript II KS(+), and transformed into E. coli.  
Thermal cycler conditions for amplification of the 5’ and 3’ flanking regions from 
genomic DNA included initial activation of FastStart Taq, 4 minutes at 95°C, 30 
cycles of amplification that included a 30 second denaturing step at 95°, 30 
seconds of annealing at 63°C, 2 minutes of elongation at 72°C.  Final extension 
was carried out for 1 cycle at 72°C for 7 minutes.  In a second round of PCR the 
5’ and 3’ regions amplified during the first round PCR are used as template, with 
the forward primer from the 5’ region and the reverse primer from the 3’ region.  
Clones were verified for the presence of the hybrid PCR product, and the 
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resultant plasmid, pJET931MA, was prepared for subsequent cloning steps 
(FIG. 5) 
The second step consisted of amplifying the nptII cassette from pKD4 (31) 
with primers that contain restriction sites matching the restriction site in the 
middle of the hybrid product from step 1.  The primers for amplifying the KmR 
cassette from pKD4 amplify a 1600bp fragment that contains two FRT sites in 
addition to the nptII cassette.  Thermal cycler conditions for amplification of nptII 
from pKD4 included initial activation of FastStart Taq, 4 minutes at 95°C, 30 
cycles of amplification that included a 30 second denaturing step at 95°, 30 
seconds of annealing at 65°C, 1.5 minutes of elongation at 72°C.  Final 
extension was carried out for 1 cycle at 72°C for 10 minutes.  Though not used 
in this study, FRT sites can be used to excise the KmR cassette by use of the 
flippase recombinase.  After the KmR cassette was amplified, it was cloned into 
the vector containing the hybrid product from first step.  This marked plasmid, 
pJET940MA (FIG. 5), was isolated from the appropriate E. coli hosts for 
electroporation into both B. abortus and B. melitensis.  
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FIG. 4. The manBA locus.  Panel A, the manBA locus was amplified using primers TAF433 and 
TAF434.  The promoter predicted by the Baylor College of Medicine Neural Network Promoter 
Prediction tool is displayed as an open circle on a stem.  Panel B, the complete vector for 
complementation of manBA knockouts. 
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FIG. 5. Vectors constructed for knocking out manBA.  pJET931MA was a stepping-stone to 
pJET940MA. 
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The manBA expression vector, pJET1445, was constructed in the broad-
host-range plasmid, pBBR1MCS6-y (107).  The vector and manBA PCR 
products were digested with Bgl II, and ligated.  Primers (TAF433/434) for 
amplifying manBA exclude the putative promoter site predicted by the Neural 
Network Promoter Prediction tool, with a threshold of 0.80, hosted by the Baylor 
College of Medicine (131).  A schematic is displayed in FIG. 4 and the exact 
sequence amplified is in Appendix A-1.  The reaction mixture was optimized for 
production of a long-template product and contained 1µl B. melitensis crude 
extract DNA from a lysozyme/proteinase K digestion, 0.5µM of each primer, 
500µM of each deoxyribonucleoside triphosphate, 2U of AccuTaq polymerase, 
1x PCR buffer, 2mM MgCl2. Thermal cycler conditions for amplification of 
manBA included initial activation of AccuTaq LA, 4 minutes at 95°C, 30 cycles of 
amplification that included a 30 second denaturing step at 95°, 30 seconds of 
annealing at 63.9°C, 4 minutes of elongation at 68°C.  Final extension was 
carried out for 1 cycle at 68°C for 10 minutes.  All samples were held at 20°C 
until being removed from the thermal cycler. 
Brucella knockout mutants were screened for ampicillin sensitivity and 
kanamycin resistance.  Southern blotting, using nylC as a probe, and PCR using 
primers TAF419/TAF420 were used to screen suspected knockouts (FIG. 6).  
Knockouts were screened phenotypically by use of acriflavine agglutination. 
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Results for the PCR screen (FIG. 6, Panel I) showed the presence of the 
anticipated 2.9kb fragment from the wild-type strain and the presence of a 1.9kb 
PCR product, indicative of the knockout.  Results from the Southern blot  (FIG. 6, 
Panel II) with the nylC probe on Hind III digested genomic DNA demonstrated 
the anticipated 10.2kb fragment from the wild-type strain the 14.8kb from the 
knockout strains. 
Complementation test confirms restoration of LPS expression in rough 
Brucella.  Knockout strains of B, abortus and B. melitensis were transformed by 
conjugation with E. coli strains carrying pJET1445.  Complementation of rough 
defect was confirmed by several phenotypic tests, including acriflavine 
agglutination, Western Blotting and direct fluorescent labeling of Brucella LPS 
(FIG. 7). 
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FIG. 6. Screening manBA knockouts.  ManBA knockouts were screened by PCR and Southern 
Blotting.  Panel I, agarose gel with PCR products A) Lambda HindIII/EcoRI, B) Distilled water 
control, C) TSB control, D) Brucella melitensis 16M wild-type product, E) Brucella abortus S2308 
wild type product, F) Brucella melitensis ∆manBA, G) Brucella abortus ∆manBA.  These results 
show the presence of the anticipated 2.9kb fragment from the wild-type strain and the presence 
of a 1.9kb PCR product, indicative of the knockout.  In Panel II, results from the Southern blot  
(FIG. 6, Panel II) with the nylC probe on Hind III digested genomic DNA demonstrated the 
anticipated 10.2kb fragment from the  wild-type strain the 14.8kb from the knockout strains.
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FIG. 7. Western blots of Brucella.  Top: Western blots of Brucella melitensis and Brucella 
abortus.  Bottom: ProQ-Emerald 300 glycoprotein staining of Brucella run on SDS-PAGE.  Lanes 
are M – Marker, A – B. melitensis 16M, B– B. melitensis ∆manBA, C– B. melitensis 16M 
∆manBA/pJET1445, D – B. melitensis 16M ∆manBA/pBBR1MCS6–y, E – B. abortus S2308, F – 
B. abortus ∆manBA, G – B. abortus 16M ∆manBA/pJET1445 H – B. abortus 16M 
∆manBA/pBBR1MCS6–y, E.c. – E. coli O55:B5 smooth strain LPS. 
   M      A      C      B     D     M    M      E      G      F     H     M 
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Results from the acriflavine agglutination showed no agglutination with 
complemented strains.  LPS production, as observed by Western Blotting and 
Pro-Q Emerald 300 staining was indistinguishable in complemented strains 
versus wild-type smooth strains. 
Complement mediated killing of rough Brucella strains.  Normal cow, 
human, and goat sera from healthy donors were tested for the ability to kill 
smooth and rough B. abortus and B. melitensis strains, as described in the 
Materials and Methods.  As shown in FIG. 8 rough B. abortus strains were 
sensitive to serum complement, whereas B. melitensis is generally resistant to 
serum-mediated killing.  Rough B. abortus strains were killed approximately 3 
logs, while smooth strains were immune to killing.  Smooth and rough B. 
melitensis strains were reduced at most by 0.3 log.  The result with B. melitensis 
mirrors results with the naturally rough, virulent B. ovis and B. canis strains (22, 
117). 
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FIG. 8. Serum mediated killing of Brucella.  Smooth and rough Brucella strains were incubated 
at 37°C with 50% normal cow, normal goat, and normal human serum for 4 hours.  Portions of 
each suspension were plated, and bacterial counts enumerated.  Values shown in the graph are 
the log of the CFU/ml in fresh serum subtracted from the log CFU/ml in heat-inactivated serum.  
The values shown for the inoculum are the CFU/ml in tryptone phosphate buffer after four hours.
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DISCUSSION 
In this study, the connection between phosphomannomutase and 
phosphomannose isomerase and LPS expression was definitively explored by 
constructing genetically defined mutants in both Brucella abortus and Brucella 
melitensis.  Previous studies looking at the connection between this locus and 
LPS biosynthesis have relied on transposon mutants, which may suffer 
downstream effects as the result of transposon insertion (4, 53, 103).  
Understanding expression of LPS biosynthesis genes is an important first step 
to being able to control biosynthesis of LPS for either vaccines or understanding 
Brucella LPS’ contribution to virulence.  
Rough strains of B. abortus and B. melitensis were derived by allelic 
exchange of the manBA locus with a kanamycin resistance cassette.  Further, 
trans-complementation of the genetic defect was achieved, restoring full 
biosynthetic properties.  Western blotting and fluorescent labeling of Brucella 
LPS demonstrated restoration of phenotype.  A functional assay examining 
resistance to serum-mediated killing showed that trans-complementation was 
effective in restoring phenotypic properties characterized for smooth Brucella 
strains (16, 29, 49, 104). 
This study opens the door to construct Brucella strains with controllable LPS 
biosynthesis to investigate the role LPS plays in Brucella virulence. 
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GENETIC CHANGES AT manBA ARE RESPONSIBLE FOR HIGH 
FREQUENCY LOSS OF LPS EXPRESSION 
 
INTRODUCTION 
The appearance of rough Brucellae in culture has been regarded as a 
random occurrence attributable to changing environmental conditions.  
Dissociation in Brucella has previously been documented for the rough vaccine 
strain, 45/20.  Unpredictable reversion to smooth phenotype was the main 
reason for discontinued use of strain 45/20 (105, 128, 129).  The genetic basis 
for smooth to rough transition in strain 45/20 remains uncharacterized. 
RB51, a spontaneously appearing rough variant of B. abortus was found to 
contain a transposon insertion in the wboA gene (139).  Complementation 
experiments attempting to restore the function of this locus did not restore the 
organism’s normal smooth phenotype.  Additional defects may have occurred 
because of in vitro passage.  The rate of appearance of rough mutants has 
never been described in the literature although anecdotal evidence suggests that 
it is significant.  The experiments described below were designed to determine 
the rate of appearance of rough variants and to determine whether this variation 
differs under in vivo conditions. 
In experiments with T-1 phage, Luria and Delbrück established the number of 
mutations per genome per generation is equivalent to the number of phage 
resistant mutant bacteria compared to the total number of bacteria in the culture 
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(97).  Further, they found that the phage resistant mutants were already in the 
bacterial culture rather than being induced by the presence of the phage.  
Generally, this frequency is 10-8 mutant bacteria per generation.  Drake has 
extended this research to find that the range for background mutation in bacteria 
is 10-6 to 10-8 mutations per generation (39, 40).  Mutation rates higher than 10-6 
mutations per genome per generation are considered mutators.   
Hypermutation in pathogenic bacteria is not unknown, and can be a method 
to affect dissociation.  Oliver et al. have conducted extensive investigations 
examining the mutation of Pseudomonas in cystic fibrosis patients, wherein they 
characterized the mutation rate to Rifampin resistant strains as 3.2 × 10-6 (109).  
One aspect of these hypermutable Pseudomonas strain is changes in the 
expression of LPS and EPS on the surface of the bacterium (118).  In fact, the 
mutation that allows Pseudomonas to adapt in cystic fibrosis patients is often the 
development of mucoid phenotype resulting from loss of control of algC, an 
ortholog of manB.  A mutation that has been shown to bring this phenotype 
about is a C to T transition in the phosphomannomutase gene (142).  Similarly, 
studies focused on Salmonella and E. coli have demonstrated hypermutable 
phenotypes in pathogenic strains, that confer an adaptive advantage to the 
bacterium in the host (15, 20, 57, 93, 108, 135). 
The work presented here paralleled the work of Luria and Delbrück, utilizing 
BK-2 Brucella phage isolated from the Isfahan strain of B. melitensis (37, 38) to 
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establish the rough content of smooth colonies.  The receptor(s) for BK-2 phage 
is largely uncharacterized, but one component is smooth LPS.  Since the 
recognition incorporates smooth LPS, only smooth strains are susceptible to 
phage-mediated killing.  This phage also has broad specificity enabling 
comparison of multiple Brucella species. 
MATERIALS AND METHODS 
Molecular biology, polymerase chain reaction, and primers.  Genetic 
manipulations were carried out as described above.  DNA Sequencing was 
performed on an ABI 3100 Genetic Analyzer at the DNA Technologies Lab , 
Department of Veterinary Pathobiology, Texas A&M University College of 
Veterinary Medicine and Biomedical Sciences.  Primers used for amplification 
with were also used for sequencing.  Sequence analysis was performed using 
Accelrys MacVector™ and DNAStar Lasergene™. 
Bacteria, plasmids, growth conditions and restriction endonucleases.  
In addition to the strains and plasmids listed in Table 2, E. coli strain AT2538 
(CGSC), Brucella melitensis 16M∆manBA, Brucella abortus S2308∆manBA 
were used.  The two manBA knockout strains are described in the previous 
chapter.  Strain 20D2 is a transposon mutant with a transposon insertion in pleD 
(BMEII0660).  All strains were grown as previously described. 
The Brucellaphage, BK2, was obtained from J. Douglas (37, 38).  
Propagation of BK-2 phage was carried out in tryptic soy broth inoculated with a 
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suspension from a 24-hour culture of B. abortus S2308, so that the final bacterial 
concentration was approximately 5 x 108 cfu/ml.  Phage was added to give a 
concentration of approximately 109 plaque-forming units.  The culture was 
incubated at 37°C, with agitation, for 18 hours.  The broth was then centrifuged 
to remove gross cellular debris and filtered through a 0.2µm polyethersulfone 
(PES) (Nalgene, Rochester, NY) membrane syringe filter. 
Rough mutant isolation from smooth colonies.  Brucella abortus and 
Brucella melitensis virulent isolates were grown on TSA to isolate individual 
colonies.  Isolation of rough mutants was carried out using independent smooth 
Brucella colonies.  Five individual colonies from each plate were suspended in 
1ml of peptone saline, each, serially diluted, and plated on TSA in the presence 
of absence of BK-2 phage.  Plates were overlaid with soft agar [7% (w/v) Bacto 
agar, 15 g/L TSB] containing at least 600,000 pfu of BK2-phage.  After 72 hours, 
the total colony forming units were enumerated. 
Determination of the background mutation rate in Brucella: Antibiotic 
resistance.  Brucella melitensis and Brucella abortus were each grown on TSA, 
verified as antibiotic sensitive, and harvested (individual colonies or whole 
plates) into peptone saline after 72 hrs at 37°C.  These bacterial suspensions 
were serially diluted and portions plated on TSA with and without antibiotics, 
including rifampin (100µg/ml), spectinomycin (100µg/ml), or gentamicin 
(10µg/ml).  The number of colonies appearing on each of these substrates wa
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enumerated.  The background mutation rate is equal to the number of colonies 
appearing on selective media divided by the number of colonies appearing on 
permissive media. 
Determination of the background mutation rate in Brucella: Pyrimidine 
auxotrophy.  To measure background mutation rate, pyrimidine auxotrophy was 
used through selection on 5-fluororotic acid (40µg/ml) in Brucella minimal media 
[BMM, 1.5% Bacto agar (w/v), 100mM NaCl, 60mM K2HPO4, 30% glycerol (w/v), 
5% lactic acid (w/v), 10mM glutamic acid, 10mM MgCl2, 5mM FeSO4, 10mM 
MnCl2, 60µM thiamine, 160µM nicotinic acid, 84µM Ca2+-pantothenate, 8µM 
biotin] containing 50µg/ml uracil.  
For determination of pyrimidine auxotrophy as a result of pyrE mutation (FIG. 
9), independent Brucella colonies were re-suspended in 200 µl peptone saline.  
This suspension was then diluted 1000-fold in fresh peptone saline.  A final 10-
fold dilution was made into 200 µl aliquots of TSB in the wells of an ELISA plate.  
The resulting cultures, each inoculated with about 1000 cells, were incubated for 
2 days, yielding visible turbidity.  Cultures were removed from incubation when  
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the cell density reached approximately 5 x 107/ml.  The density of viable cells 
was determined by plating a subset of these cultures on non-selective media.  A 
70-µl aliquot of each culture was plated on selective medium, and FOA-resistant 
colonies were analyzed after 8-10 days of incubation unless otherwise noted.  
As a positive control, the E. coli, uracil auxotroph strain, AT2538 was carried 
through all steps of the experiment.  The pyrE mutation rate was calculated from 
a total of 94 independent B. abortus and B. melitensis colonies respectively.  
Mutants from the pyrE study were randomly chosen for sequence analysis by 
applying the technique of Grogan et al. (65).  Mutants were chosen for 
sequencing by marking a small dot on the back of the Petri plates on the day 
that cultures were plated.  The colony closest to the dot was chosen for 
sequencing.  Portions of each of the clonally pure culture were preserved at -
70°C. Total genomic DNA was extracted from the remainder of the culture by 
use of lysozyme digestion followed by proteinase K digestion. 
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FIG. 9. Co-opting the pyrimidine biosynthetic pathway.  The normal pyrimidine biosynthetic 
pathway in Brucella melitensis is shown on the left.  The addition of 5-fluoroorotic acid (FOA) co-
opts the pathway, resulting in cell death.  Cells may avoid death by inactivation of either pyrE or 
pyrF (shown in red).  The gene designations are as follows: pyrA, carbamoyl-phosphate 
synthase (EC 6.3.5.5, BMEI0522, BMEI0526, BMEI1781); pyrB aspartate carbamoyltransferase 
(EC 2.1.3.2, BMEII0670); pyrC, dihydroorotase (EC 3.5.2.3, BMEI1281, BMEII0669); pyrD, 
dihydroorotate dehydrogenase (EC 1.3.3.1, BMEI1611); pyrE, orotate phosphoribosyltransferase 
(EC 2.4.2.10, BMEI1295); pyrF, orotidine 5'-phosphate decarboxylase (EC 4.1.1.23, BMEI1999); 
pyrH, uridylate kinase (EC 2.7.4.4, BMEI0825); pyrG, CTP synthetase (EC 6.3.4.2, BMEI0850). 
Adapted from (84, 90). 
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Phenotypic confirmation of rough mutants.  Rough mutants from were 
confirmed for rough phenotype by acriflavine agglutination (6).  Ten microliters of 
bacteria from an 18-24 hour liquid culture, is spotted onto a glass slide.  This 
sample is mixed with 10µl of a 0.1% (wt/vol) aqueous solution of acriflavine.  
Agglutination indicates a rough phenotype (6).  Alternatively, crystal violet 
staining was used to test the presence of rough colonies on plated media, when 
harvesting a single colony was undesirable.  The dye [2%(wt/vol) crystal violet 
dye, 20% (vol/vol) ethanol, 0.8% (wt/vol) ammonium oxalate] was used to flood a 
Petri plate containing the bacteria; colonies formed from rough mutants will 
absorb the dye readily and turn a dark purple.  This dye is excluded by smooth 
colonies.   
Genotypic tests for rough mutants.  The presence of manBA was 
determined for all spontaneous rough isolates by PCR amplification.  Cultures 
were grown 16-24 hours in tryptic soy broth.  Samples were applied to an FTA 
CloneSaverTM card, which inactivates the bacteria (Whatman).  Two-millimeter 
punches were taken from each sample and used in a subsequent PCR.  
Complementation tests with the expression vector pJET1445 were performed for 
each mutant as previously described 
Recovery of rough isolates from mice.  Bacterial strains were grown on 
TSA plates and harvested in 5 ml of PBS.  The bacterial concentration of 
suspension was estimated with an absorbance spectrophotometer, and adjusted 
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to a concentration of approximately 5 x106 CFU/ml.  Plating the inocula and 
enumerating total CFU confirmed the infectious dose.  Six to eight week old mice 
were injected with 100µl, in six parallel groups.  The different inocula consisted 
of pure populations of Brucella melitensis 16M, Brucella melitensis 
16M∆manBA, 1:1 B. melitensis 16M wild type and ∆manBA and the same 
strains on a B. abortus background.  The mice were sacrificed at 1 and 8 weeks 
post-inoculation by CO2 asphyxiation.  Spleens were collected from each group, 
spleen weight was determined, and spleens were homogenized with a tissue 
homogenizer (Omni 2000; Omni International, Inc.) for determining bacterial 
load.  In addition to plating on TSA with appropriate antibiotics, a portion of each 
homogenate was plated on BK-2 phage as previously described, for 
enumeration of total rough bacteria.  Data are the average log10 value of CFU 
per spleen over five mice. 
In vitro competitive growth.  Genetically engineered rough B. melitensis 
was mixed with wild-type B. melitensis 1:1 in 5 ml of TSB.  After 48 hours, 50µl 
was removed and passaged to fresh TSB for further culture.  This was repeated 
for three passages.  The rough content of each passage was ascertained by 
differential plating. 
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RESULTS 
Dissociation rate determination.  The dissociation rate for 60 B. melitensis 
and 59 B. abortus individual smooth colonies was determined.  The number of 
rough colonies derived from each single smooth colony was enumerated, the 
ratio, rough cfu/smooth cfu from each smooth colony is the dissociation rate.  
The rate of dissociation for B. melitensis is 1.15 x 10-4, while the frequency of 
dissociation of B. abortus rough variants is 1.27 x10-5.   
In order to assess the appearance of rough mutants in vivo, mice were 
inoculated with 5 x105 CFU of each strain (smooth, rough) or a 1:1 mixture of 
smooth and rough.  The survival and virulence characteristics were compared 
over eight weeks.  The rate of dissociation remained similar to the in vitro model.  
After 1 week, rough mutants were isolated from mice infected with smooth B. 
melitensis at frequency of 5.94 x 10-3 and mice infected with B. abortus had a 
dissociation rate of 9.95x 10-3.  After 8 weeks, these frequencies changed only 
slightly to 1.42 x 10-2 and 6.44 x 10-4 respectively.  Mice infected with pure rough 
populations eliminated the bacteria rapidly; both B. melitensis and B. abortus 
rough strains were below the limit of detection after 1 week, and B. abortus 
rough mutants recovered slightly towards 8 weeks.  In mice infected with 1:1 
ratios of smooth and rough bacteria, rough strains were recovered out to 8 
weeks, at similar frequencies to animals infected with pure populations of 
smooth strains.  Since the marked mutant was not recovered from these 
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animals, these roughs represent newly derived mutants from the smooth portion 
of inoculum (FIG. 10). 
Mutation rate estimation.  Luria-Delbrück fluctuation calculations were 
applied to multiple independent cultures to estimate the rates of pyrE or manBA 
mutation.  The method of the median is generally accepted as an unbiased 
method to determine the mutation rate in bacterial populations (86, 124).  The 
method consists of calculating the median number of mutants and using that 
number to find the theoretical number of mutants per culture from the tables of 
Lea (92).  Attempts to establish the background mutation rate of Brucella by 
spontaneous appearance of antibiotic resistant colonies were inconclusive due 
to the lack of isolation of resistant colonies.  Based on the median culture size 
(approximately 108/ml), the rate from this test is less than 10-8 mutations per 
genome per generation.   
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FIG. 10.  Recovery of rough Brucella in mice at 1 and 8 weeks.  Data is presented as 
log10 value of bacteria present in spleens, averaged over 5 mice.  The limit of detection (L.O.D.) 
is less than 50 organisms.  Solid arrows represent the initial inoculum. 
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An alternative approach utilizing auxonography was utilized.  Growth on the 
toxin 5-fluororotic acid selects mutants deficient in either of two UMP 
biosynthetic enzymes: orotate phosphoribosyl transferase (OPRTase) and 
orotidine 5'-monophosphate decarboxylase, encoded by the pyrE and pyrF 
genes, respectively (65).  FOA is not toxic outright, but the 5-F-UMP made from 
it by sequential action of the two enzymes kills cells (FIG. 9).  Loss of either 
enzyme thus spares the mutant in the presence of FOA, but also renders it 
dependent on exogenous uracil for growth.  The parameters needed to calculate 
the background mutation rate were derived from 94 independent B. abortus and 
B. melitensis cultures.   
With the exception of jackpot cultures (>>3000 colonies/plate), 261 mutant 
colonies were collected from B. abortus, and 930 mutant colonies were collected 
from B. melitensis.  Median numbers of mutants for these cultures were 2 and 
18.5, respectively.  The most probable number of mutational events per culture 
for the set, m, was determined by using the method of the median of Lea and 
Coulson (92, 97, 124).  This leads to an estimation of 1.32 and 6.07 mutational 
events per culture for B. abortus and B. melitensis respectively.  To calculate the 
average number of cells per culture, the viable titers were determined by serial 
dilution and plating on nonselective medium.  Values were averaged, deriving 
the average number of bacteria in a given culture (Nav).  Mutation rate per cell 
generation, µ, was calculated by using the relationship µ = (ln2)(m/Nav).  For B. 
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abortus this value was 1.63 x 10-8, and for B. melitensis 7.48x 10-8 mutations per 
genome per generation.  This indicates an extremely stable genome.Similar 
experiments were carried out to estimate the mutation rate for manBA.  The 
theoretical number of mutations per culture (m) was found in two ways.  Using 
the median of all rough colonies (B. melitensis or B. abortus) to find m, led to m= 
293 mutations per culture, for B. melitensis and m=312 mutations per culture for 
B. abortus.  Using the median of only those colonies complemented by manBA 
in trans, m=197 mutations per culture for B. melitensis and 331 mutations per 
culture for B. abortus.  Luria-Delbrück mutation frequencies, µ, were calculated 
for each method.  In general the rate of mutation is about 6 times greater than 
that observed for reversion of E. coli auxotrophy and 2 times greater than the 
rate observed for S. typhimurium (39).  Mutation rates for manBA are about 100-
1000 times greater than the rate of mutation resulting in loss of function of lacI in 
E. coli (39).  These rates, summarized in Table 4, are consistent with a mutator 
phenotype.  
Genotypic tests for rough mutants.  Contribution of genetic events at the 
manBA locus was assessed by PCR, Southern blotting, and a complementation 
test for each mutant.  For the complementation test, plasmid pJET1445 (Table 2, 
FIG. 4) was introduced into each rough isolate to determine if a defect in manBA 
was the reason these strains had lost LPS expression.  Indeed, 36.67% of B. 
melitensis, 20.34% of B. abortus, and 28.57% overall rough mutants
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Table 4. Dissociation frequency, mutation rate, mutation frequency and complementation 
test results for B. melitensis and B. abortus.  
In the column for mutation frequency, column A represents all rough, while column B 
represents only those rough complemented by manBA in trans. 
Species Dissociation 
frequency 
Mutation 
Rate 
Mutation Frequency Complementation 
Test 
   A B  
B. melitensis 1.15 x 10-4 293 1.27 x 10-3 1.25 x 10-3 36.67% 
B. abortus 1.27 x10-5 312 1.95 x 10-4 2.06 x 10-4 20.34% 
 
 
 
57 
 
were complemented by manBA in trans.  This complementation test represents 
the first time LPS expression has been fully restored to any O-antigen deficient 
Brucella strain.  The ability of this expression vector to restore 
lipopolysaccharide expression in manBA deficient strains was confirmed by both 
Western blotting (FIG. 7) and staining with Pro-Q Emerald 300, a glycoprotein 
stain (FIG. 7).  
PCR and Southern blots failed to show gross rearrangements at manBA, but 
sequencing did show change that may be related to the loss of function.  In 
sequenced roughs, two transitions, T135C and G335A were found.  These 
transitions cause a coding shift from serine to leucine and glutamic acid to 
glycine, respectively.  Both transitions are found within the putative 
phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain I of 
phosphomannomutase (manB, BMEII0899) (98).  Presumably, similar 
polymorphisms exist in spontaneous roughs that still need to be sequenced.  
Thermal cycler conditions for amplification of manBA for screening spontaneous 
rough isolates, using primers TAF419 and TAF420 were developed.  The 
reaction mixture contained a 2mm punch from a Whatman FTA CloneSaverTM 
card that had sample applied to it from a liquid Brucella culture.  Punches were 
prepared for PCR according to manufacturer instructions.  Further, the reaction 
mixture contained 0.6µM of each primer, 500µM of each deoxyribonucleoside 
triphosphate, 1U of AccuTaq LA polymerase, 1x PCR buffer, 2mM MgCl2.  
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Instrument conditions included activation of the polymerase at 98°C for 30 
seconds, 30 cycles of amplification with 94°C x 30 seconds melting, 58°C 
annealing x 30 seconds, and 68°C x 3 minutes elongation.  A final elongation 
was performed one time at 68°C for 10 minutes. 
Rough B. melitensis grow faster than smooth strains.  The ability of 
rough strains to outgrow smooth strains was test in a competitive assay over five 
passages.  Starting with a ratio of 1:1, the engineered rough mutant was found 
to outgrow the smooth variant 2:1 by the end of three passages (FIG. 11). 
Creation of non-dissociative Brucella  strains.  To see if dissociation 
could be prevented, smooth Brucella melitensis isolates were transformed with 
pJET1445, containing wild-type copies of the B. melitensis manBA genes.  BK-2 
phage was used to test the rate of appearance of rough isolates from this non-
dissociative strain.  Dissociation rates of these strains were indistinguishable 
from wild-type B. melitensis. 
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FIG. 11. Rough Brucellae outgrow smooth Brucellae over time.  Smooth and rough 
strains were mixed 1:1 and grown in 5 ml of TSB.  Strains were passaged every 48 hours.  
Bacterial CFU were enumerated by differential plating.  Each data point is the average of two 
independent trials, ± standard deviation. 
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FIG. 12. Preliminary screen of Brucella rough mutants.  A) Spontaneous rough isolates 
contain a 12kb deletion.  Genomic DNA was prepared and digested from virulent Brucella and 
rough isolates (R1-R13).  The digested DNA was electrophoresed and Southern blotted.  
Detection was performed by using a randomly 32P labeled probe for type-6-aminohexanoate, 
immediately upstream of manBA.  The full extent of the deletion was characterized by primer 
walking.  B) the manBA locus, showing the full extent of the deletion that was originally 
characterized.  The dark blue genes are undeleted, the light blue genes are partially deleted and 
red genes are completely removed. 
 
61 
 
DISCUSSION 
Preliminary analysis revealed that there were two genotypes associated with 
spontaneous rough mutants present in stock cultures obtained from ATCC.  One 
of these genotypes is a deletion of a 12kb region of the genome encompassing 
a region that includes the manBA locus as revealed by Southern blots of 
genomic DNA, cloning and sequencing (FIG. 12).  The second genotype 
contained no detectable rearrangement when measured at the manBA locus.  
This fits the expectation that more than one locus is involved in the loss of O-
antigen, though trans-complementation restored LPS expression in each of 
these strains (both types).  In the process of collecting additional, non-sibling, 
rough mutants from a virulent isolates of B. melitensis and B. abortus, we were 
unable to show a large deletion, but were able to demonstrate trans-
complementation of LPS deficient strains in approximately 30% of isolates.  
Deletion events could represent rare endpoints of smooth to rough transition. 
Utilizing a Poisson approximation for the binomial distribution, we calculated 
the number of rough mutants needed in order to investigate all twelve of the 
known genes that could cause a rough phenotype.  A listing of these genes is in 
Table 1.  Using Poisson’s distribution, sample size can be chosen for the 
probability of showing a defect in at least one individual.  This is an extension of 
the methods used to estimate the number of mutants needed to saturate a 
genome during signature tagged mutagenesis: 
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! 
n = "
ln(1" #)
p
 (i) 
where n= sample size, γ=probability of finding at least one defective gene, 
p=estimated proportion of defective genes in our population (1 out of 12 genes).  
For 99% confidence: 
! 
n = "
ln(1" 0.99)
1
12
=
4.61
0.08
= 57.63 # 58 mutants (ii) 
The number of mutants needed to reach saturation increases rapidly with the 
number of potential targets (Table 5). 
In vitro growth characteristics of rough strains were established in 
competition to smooth strains (FIG. 11).  Though the rough mutant outgrows the 
smooth strain, the rate is linear, as opposed to the logarithmic dissociation 
frequency.  In vivo, it is anticipated that the rough would not outgrow the smooth 
strain since the rough mutant is readily killed.
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Table 5. Increase in the number of mutants that needed to be screened in proportion to 
the suspected contributing genes. 
Confidence Level Number of Candidate 
Genes 99% 95% 90% 
12 55 36 28 
13 60 39 30 
25 115 75 58 
50 230 150 115 
100 461 300 230 
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In vivo, the frequency of dissociation was found to be similar to the frequency 
with which rough isolates were found in smooth colonies.  Smooth to rough 
transition is not simply an in vitro artifact, as has been suggested, but represents 
a real event that may be the result of adaptation to the host environment.  The 
role that LPS plays in acquiring the host is just beginning to be understood, and 
some modification of the LPS may occur within the host.  Dissociation has been 
demonstrated in many gram-negative bacteria.  The major difference between 
this and other regulatory mechanisms is that it is mediated by changes to the 
DNA, which can occur during replication, rather than in response to a stimulus 
(44, 73, 126).  There are many mechanisms for dissociation including inversions 
and transposon movement.  The Brucella genome is replete with transposons 
and repeat regions that could be involved.  Bacteria have diverse methods for 
changing the expression of their genes by changing their genomes. 
Establishing the background mutation rates for Brucella is an important 
component of the overall project goal of determining the significance of the rate 
of appearance of rough variants.  To accomplish this, a bank of antibiotics was 
used.  This method has been successful in determining the frequency of mutator 
phenotypes of pathogenic forms of E. coli, Salmonella, and Pseudomonas from 
108 bacteria (93, 130).  The selection of these antibiotics was determined by 
their mechanism of action, in order to compare as wide a variety of cellular 
functions (replication, transcription, and translation) as possible.  However, 
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Brucella cultures failed to produce any mutants by this method.  Instead, 
conversion to pyrimidine auxotrophy was used to examine the background 
mutation rate.  As expected, Brucella demonstrated a very low rate of mutation.   
In order to determine what the rate of appearance of rough variants is under 
in vivo growth conditions, mice were infected with smooth, pure rough and mixed 
smooth and rough inocula.  Spleens of infected mice were harvested at 1 or 8 
weeks post inoculation.  There was essentially no difference in the rate of 
smooth to rough transition in the host compared to isolation from smooth 
colonies. 
Attempts undertaken to prevent the appearance of rough mutants by 
inclusion of manBA in trans in smooth strains were unsuccessful.  The 
appearance of rough mutants from transformed smooth strains was essentially 
the same as from wild-type strains.  Since this genetically modified smooth strain 
contains approximately ten copies of each plasmid, the appearance of rough 
mutants was expected to be a rare event.  Loss of the plasmid is a possibility.  In 
order to assure plasmid retention, chloramphenicol was maintained during in 
vitro studies.  Failure to maintain the plasmid will produce results 
indistinguishable from smooth or rough organisms depending on the genetic 
background employed.  A second mechanism that could limit interpretation is 
silencing of essential gene functions by trans acting factors including DNA 
methylation or gene regulation.  In such a case the presence of multiple gene 
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copies may not be sufficient to counteract such a mechanism and rough variants 
may still appear. 
Emergence of spontaneous rough mutants could involve changes at a single 
locus or at multiple loci.  Current evidence suggests major rearrangements are 
possible, whether this is a rare event or part of a programmed process is not 
clear.  Furthermore, large deletions would appear to limit survival unless the 
presence of these rough organisms enhances survival of the overall population.  
In this study, rough mutants were found to be the result of base transitions 
occurring within the active site of phosphomannomutase.  Both base transitions 
replace a hydrophobic residue within the active site.   
Evidence described elsewhere suggests the presence of a population of 
spontaneous rough organisms that revert to full virulence (128, 129).  However, 
the frequency of such events is not known.  It is clear that rough mutants induce 
greater levels of inflammatory cytokines upon interaction with macrophages 
indicating presence of O-antigen is important for preventing cellular activation 
(121).  Prevention of activation enhances survival.  The fact that rough mutants 
are observed at the same frequency in vivo as in vitro argues for a role in 
survival or dispersion of the bacteria throughout the host.  Hypermutation can 
offer substantial improvement in adaptive potential.  Preservation of this 
hypermutable trait may reflect the ancestry of the strain, as the closely related 
Rhizobia (55) also dissociate from LPS.  Loss of LPS in Rhizobium has been 
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shown to cause defects in colonizing the root nodule.  The ultimate pathogen 
would possess transient mutation that confers adaptive advantage in the host 
environment.   
During the course of this work, the signature-tagged mutagenesis project 
revealed a rough mutant that could be complemented by manBA in trans, but 
was not defective in manBA.  A two-component response regulatory element, 
pleD, was inactivated by insertion of mini-tn5.  Acriflavine agglutination revealed 
that this strain was rough, and attempts to complement this rough defect with 
pJET1445 were successful.  The role of pleD in LPS expression, is unclear, but 
studies in other organisms have shown that it plays a role in cell division in 
Caulobacter crescentus and cellulose biosynthesis in Rhizobia  (3, 9, 99).  
Rhizobia pleD null mutants produce long cellulose tendrils from the surface of 
the bacterium, rather than a uniform capsule.  The role of pled needs further 
investigation.  Mutations at second sites in the genome may affect the 
expression of manBA at its native promoter, contributing to dissociation.  This 
may account for lack of gross rearrangements at manBA, though pJET1445 was 
able to complement loss of function.  The complementation plasmid, pJET1445 
does not carry the putative promoter for manBA. 
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LPS PROMOTES ‘PROPER’ INNATE IMMUNE RESPONSE 
 
INTRODUCTION 
Lipopolysaccharide is commonly accepted as an essential virulence factor for 
Gram-negative bacteria because it is necessary for survival of classical strains 
(B. suis, B. abortus, B. melitensis).  Contradictory to LPS’ classical role as an 
inflammatory agent, Brucella LPS actually limits macrophage activation, which is 
the hallmark of its traits as a virulence factor (91).  In this aim, the main goal of 
the experiments were to characterize the role of Brucella LPS articulating uptake 
and survival of smooth organisms.  Nitric oxide and cytokine production levels 
were also measured.  Finally, the ability of smooth and rough to recruit the 
macrophage in the host was compared by using a short-term mouse model that 
looked mainly at invasion. 
Though trafficking of Brucella is documented in several cell types, 
macrophages appear to be particularly important to the spread of Brucella 
throughout the host (95).  To illustrate the connection between Brucella LPS with 
uptake and survival, LPS knockout mutants with or without complementing 
plasmid were compared to survival of the parental smooth strain.  The murine 
macrophage cell-line, J774A.1 is well characterized and widely used for 
screening Brucella mutants and was used here for comparative purposes (8, 34, 
68, 72, 78, 79, 96, 112). We observed restricted activation of macrophages by 
smooth Brucellae characterized by reduced production of reactive nitrogen 
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intermediates and reduced cell death (necrosis).  Understanding the function of 
Brucella LPS in a productive infection compared to the abortive infection 
observed with rough Brucella will provide greater insight about the role LPS 
plays in acquiring the host. 
The mouse model is well established in Brucella research.  With previous 
murine models of brucellosis, it has been shown Brucella administered 
intraperitoneally results in colonization of the spleen and peripheral lymph (4, 5).  
This study used two approaches to the mouse model, to answer distinctly 
separate questions.  One of the issues approached was to assess the survival of 
B. melitensis smooth and rough mutants at acute (1 week) and chronic (5 
weeks) stages of infection in the mouse.  Since this study is seeking to define 
the role of LPS in host cell/bacterial interaction, the more important question 
asked was about the acquisition or recruitment of the host environment by the 
pathogen.  This experiment was designed to ask which host cells were recruited 
to the site of infection and what cytokine responses were elicited in the host.  
Innate immune response to Brucella is mediated by professional phagocytes 
(8, 11, 18, 87).  In macrophages, cytokines typically studied include the 
proinflammatory cytokines, IL1α, TNFα, IFNγ, and the proinflammatory cytokine 
antagonist, IL10.  Compared to E. coli, Brucella strains are poor inducers of 
cytokines in the macrophage model (121).  However, work in the mouse model 
has shown that smooth Brucella LPS is an antagonist of proinflammatory 
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cytokines (21).  This inflammatory response appears to be mediated through the 
toll-like receptor 4 pathways.  Herein, data is presented from infection of mice, 
that corroborates the proinflammatory nature of Brucella LPS in the mouse 
model. 
MATERIALS AND METHODS 
Bacteria, plasmids, growth conditions and restriction endonucleases.  
All bacterial strains used in this study are listed in Table 2.  Additionally the 
16M∆manBA, 16MR1, 16MR6, and S2308∆manBA from the second study were 
used in this study.  16MR1 and 16MR6 are spontaneous roughs isolates that 
can be complemented by manBA in trans.  All strains were grown as previously 
described.  
Macrophage infection.  Macrophage infection by Brucella is standard 
practice.  Monolayers of cells are cultured in tissue culture plates; bacteria were 
added to J774A.1 macrophages at multiplicity of infection (MOI) of 100.  The 
infected cell culture plate was centrifuged (room temperature, 200g, 5 minutes) 
to associate the bacteria with the macrophage monolayer.  Cell cultures were 
placed in a 37°C incubator in the presence of 5% CO2 for 20 minutes.  The 
infected monolayers were then washed three times with peptone saline.  Tissue 
culture media containing Gentamicin was added back to monolayer, killing 
bacteria external to the macrophage.  At each time point, the cell supernatant 
was removed to determine cytokine levels, nitric oxide levels or lactate 
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dehydrogense (LDH) response, as appropriate.  Invasion was judged after 1 
hour by lysing the macrophage monolayer and plating the lysate on TSA with or 
without appropriate antibiotics.  To measure uptake, the recovered bacterial CFU 
is compared with the infectious dose.  Survival was judged at later time points.  
Supernatants collected at indicated time points were stored at –80°C for cytokine 
and nitric oxide detection. 
LDH assay to measure cell death.  Cells cultured in 24-well plates were 
infected with B. abortus in triplicate wells as described above.  Culture 
supernatants were collected at various time points post-infection, and the lactate 
dehydrogenase (LDH) release was determined by use of the CytoTox 96 non-
radioactive cytotoxicity assay (Promega, Madison, Wisconsin) according to the 
manufacturer's instructions.  Cell death is expressed as a percentage of 
maximum LDH release, i.e., 100 x (optical density at 490 nm [OD490] of infected 
cells - OD490 of uninfected cells)/(OD490 of lysed uninfected cells - OD490 of 
uninfected cells).  This assay was performed in triplicate; data shown is the 
average of three independent experiments, ± the standard deviation. 
Assay to measure release of nitric oxide.  Nitric oxide in tissue culture 
supernatants was detected using Griess Reagent (Sigma).  Fifty microliters of 
the culture supernatants were mixed with 50 µl of Griess regent in 96-well assay 
plate and incubated for 15 min at room temperature.  Sodium nitric solutions with 
1 to 50 µM concentrations were included as standards.  This assay was 
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performed in triplicate; data shown is the average of three independent 
experiments, ± the standard deviation. 
Murine infection assay (Long-term).  Bacterial strains were grown on TSA 
plates and harvested in 5 ml of PBS.  The bacterial concentration of suspension 
was estimated with an absorbance spectrophotometer, and adjusted to a 
concentration of approximately 5 x 107 cfu/ml of Brucella melitensis wild type or 
5 x 108 cfu/ml Brucella melitensis rough mutant.  Plating the inocula and 
enumerating total CFU confirmed the infectious dose.  Four groups of 5 mice 
each, 6 week old BalbC/ByJ mice were injected with 100µl, in parallel groups.  
The mice were sacrificed at 1 and 5 weeks post-inoculation by CO2 
asphyxiation.  Spleens were collected from each group and homogenized with a 
tissue homogenizer (Omni 2000; Omni International, Inc.) for determining 
bacterial load.  Data are represented as average log10 value of CFU per spleen 
for each mouse. 
Murine infection assay (Short-term).  To evaluate uptake in the mouse 
model, two groups of 8 mice each were infected parenterally via peritoneal 
injection with either B. melitensis wild type or the manBA deletion mutant with 1 
x 108 cfu/mouse.  Mice were sacrificed at 1-, 4-, 8-, 24-, and 72-hour time points.  
Samples from the mice were evaluated for bacterial survival, cellular infiltration 
of the peritoneum, and cytokine responses.  Cell-mediated responses were 
quantified using differential cell analysis based on morphology, a common 
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clinical approach used to distinguish different cytological populations.  Samples 
of spleen, liver, and mesenteric lymph node were collected, fixed in 10% 
formalin.  Texas A&M University’s College of Veterinary Medicine histology 
service performed the embedding and sectioning of these tissues for later 
analysis. 
Cytokine analysis.  Initial characterization of cytokine response was carried 
out using the RayBio® Mouse Cytokine Antibody Array II from RayBiotech 
(Atlanta, GA), as per manufacturer instruction.  The sample applied was ascitic 
fluid from infected mice. 
Evaluation of cytokine production was carried out by way of a sandwich 
ELISA.  Whole animal cytokine profiles were developed on recovered ascites 
and serum (51, 111).  All cytokines, unless otherwise stated, were detected 
using sandwich ELISA development kits purchased from PeproTech, Inc. (Rocky 
Hill, NJ), following the manufacturer’s instructions. 
RESULTS 
Evaluation of infection by rough and smooth B. melitensis in murine 
macrophages.  Both rough and smooth bacteria were internalized by the mouse 
macrophage cell-line J774A.1.  At early time points, 0, 4, and 8 hours, it was 
apparent that rough bacteria were being internalized approximately 10-fold more 
than smooth bacteria.  After 24 hours, the outcome for rough bacteria was 
markedly different from smooth bacteria, with a sharp reduction in bacterial
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numbers recovered, with the exception of the rough strain 16MR6.  Smooth 
bacteria appear to have begun to replicate within the macrophage environment, 
as evidenced by an increase of one order of magnitude (FIG. 13). 
Infection of macrophages with rough B. melitensis causes macrophage 
death.  Inspection of infected macrophages revealed that macrophages infected 
with rough B. melitensis were undergoing cell death.  This was quantitated using 
an assay that measured the release of LDH to the media.  High quantities of 
LDH in the media of macrophages infected with rough strains after 24 hours 
indicated that these cells were dying, while cells infected with smooth strains 
showed little cell death (FIG. 14).  In fact, observations of cells infected with 
smooth strains showed that there was no gross morphological difference 
between these cells and uninfected cells.  Cell death may be the endpoint of 
activation.  Consistent with activation mediated death of macrophages was the 
release of reactive nitrogen intermediates, as measured by Griess reagent.  
Generally, more reactive nitrogen was observed from macrophages infected with 
rough Brucella (FIG. 15). 
Survival of rough Brucellae in mice (long-term).  The survival 
characteristics of rough and smooth Brucella melitensis were assessed in the 
mouse model of brucellosis.  Since the literature concerning rough mutant 
survival in mice has already made apparent that rough mutants are attenuated, 
the rough mutant dose was increased relative to the smooth inoculum.  The 
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result was a significant decrease of spontaneous rough isolates in the mice by 1 
week, with all rough mutants being significantly attenuated at 5 weeks (FIG. 16).  
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FIG. 13. Infection of murine macrophages by rough and smooth B. melitensis.  Bacteria 
were grown overnight at 37°C, then left in contact with macrophages for 1 hour.  Monolayers 
were washed and further incubated with gentamicin containing media for the specified amount of 
time.  At the selected time points, macrophages were lysed and total numbers of bacteria were 
enumerated by plating serial dilutions on TSA.  Data shown are the mean ± standard deviation 
(error bars). 
a
) 
b
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c
) 
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FIG. 14. Rough Brucella melitensis are cytotoxic in macrophages.  J774A.1 
macrophages are infected with Brucella at an MOI of 1:100.  To synchronize infection, the 
infected cells were centrifuged 5 minutes, incubated 20 minutes.  The tissue culture media is 
removed and replaced with media containing Gentamicin, which kills all the extracellular 
bacteria.  At each time point, media is removed from each well and assayed for the release of 
lactate dehydrogenase, an indicator of host cell lysis.  The bright field microscopy images are 
smooth and rough Brucella infected macrophages at 24 hours post infection, respectively.  In the 
graph, LDH values are shown as they relate to the percent cell death of the macrophage 
monolayer.  Values with a single asterisk are significant for all rough strains versus the wild-type 
smooth strain, 16M.  Values with a double asterisk are significant for the manBA allelic exchange 
knockout mutant.  This assay included Brucella melitensis 16M, 16MﾆmanBA::KmR, and one 
each type of the spontaneous rough isolates of Brucella melitensis, R1 and R6 
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FIG. 15. Release of nitric oxide is greater in macrophages infected with rough Brucella.  
J774A.1 macrophage-like cells were infected as described in the Materials and Methods.  
Supernatants were assayed for reactive nitrogen 24 hours post-infection.  Data is averaged over 
three independent assays ± standard deviation.  Differences between isogenic smooth and 
rough strains are significant (p<0.05) by use of Student’s t test.  Differences between all strains 
and uninfected control are significant. 
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FIG. 16. Rough B. melitensis is attenuated in the mouse model of infection at both acute 
and chronic time points.  Mice were infected with smooth and rough B. melitensis as indicated in 
the materials and methods.  Spleens were removed at the indicated time points and total 
bacterial load per spleen was determined.  Data on the graph indicate recovery from individual 
mice, with a solid bar to indicate median infection level.  At one week post-infection, significant 
differences between the smooth and rough are indicated with an asterisk.  At five weeks post 
infection all rough strains a significantly attenuated.  Significance was judged using Student’s t  t-
test and p<0.05. 
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Acquisition of the host environment.  As a measure of the bacterium’s 
ability to acquire cellular targets in a host model of brucellosis 8 mice were 
infected parentally with wild-type B. melitensis 16M and 8 mice with the 
engineered rough strain, 16M∆manBA.  Within 1 hour of infecting the mice, there 
was a 1-log difference between smooth and rough strains, reflecting the severe 
attenuation of rough Brucella in an animal model. 
Consistent with the observations in the macrophage model, rough bacteria 
acquired the host cell sooner than smooth bacteria, as measured by the use of 
gentamicin to treat recovered ascities (FIG. 17).  At early time points there was 
one order of magnitude more extracellular smooth bacteria in the ascities than 
intracellular bacteria.  In the case of rough bacteria, most had acquired a host 
cell.  Both populations decrease in the ascities, presumably as the bacteria are 
trafficked to peripheral organs (FIG. 17). 
Bacterial load in the spleen and liver essentially parallel one another.  In the 
case of both the smooth and rough, bacterial load in the spleen and liver 
essentially remain the same from 1 hour until about day 7.  Rough strains never 
colonize these organs to the same extent as smooth strains, presumably to 
killing as the bacteria traffic to these organs.  Interestingly, there is an increase 
in rough bacteria present in the spleen between day 3 and day 7, while there is a 
decrease in rough bacteria present in the liver (FIG. 17). 
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Total cellularity was assessed in mice infected with both rough and smooth 
bacteria.  There were no significant differences in total cellular numbers elicited 
by smooth or rough bacteria or from mice injected with a similar volume of PBS.  
However, differential cell analysis found differences in the cellular populations 
recruited by smooth and rough bacteria.   
In mice infected with smooth bacteria, the major cell populations present 
between 24 and 72 hours were macrophages, while mice infected with rough 
bacteria presented more neutrophils in their ascities.  By 24 hours, differential 
cell count in animals infected with smooth bacteria revealed approximately 60% 
of neutrophils, 25% of macrophages, and 15% of other nucleated cells including 
mesothelial cells and lymphocytes.  By contrast, the cellularity in mice infected 
with rough Brucella revealed approximately 70% of neutrophils, 20% of 
macrophages, and 10% of other nucleated cells including mesothelial cells and 
lymphocytes.  For both strains at this time point, macrophages often contained 
large numbers of intracytoplasmic bacteria and clear vacuoles.  By 72 hours, the 
population of cells found in the peritoneum of mice infected with smooth bacteria 
had not changed, 60% of macrophages, 25% of neutrophils, and 15% of other 
nucleated cells including mesothelial cells and lymphocytes.  Meanwhile, mice 
infected with rough bacteria showed peritoneal population consisting of 75% of 
neutrophils, 15% of macrophages, and 10% of other nucleated cells including 
mesothelial cells and lymphocytes.  In uninfected mice, the vast majority 
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(approximately 90%) of the nucleated cells present were medium-sized round 
cells with a single, blue, hyperchromatic, round nucleus, moderate amounts of 
pale to blue cytoplasm containing a peripheral red rim, presumably mesothelial 
cells.  Macrophages and neutrophils were rarely observed (FIG. 18). 
Mice release higher amounts of proinflammatory cytokines on 
challenge with smooth organism.  Gram-negative bacteria usually stimulate 
high levels of pro-inflammatory cytokines, owing to the activity of Lipid A.  
Difference in cytokine expression, because of infection by rough or smooth 
bacteria could account for the difference in virulence between bacterial strains.  
To narrow the scope of pro-inflammatory cytokines screened from the mouse 
model of infection, a protein based cytokine array was used to determine 
differential expression of cytokines in mice infected with rough or smooth 
Brucella.  Samples applied to these arrays were pooled from mice from each 
group over all time points.  The output from this array (FIG. 19) showed 
increased induction of the pro-inflammatory cytokines IL6, IL12, IFNγ, MIP2, and 
TNFα in mice infected with smooth strains.  Levels of some key chemokines, 
KC, MCP1, TIMP1, were greater in rough Brucella infected mice. 
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FIG. 18. Total cellularity as the result of infection.  The total cells per milliliter PBS were 
collected to assess whether smooth or rough Brucella elicited inflammatory cells to the 
peritoneum in different quantities.  Values shown are the average and the standard deviation.  
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ELISA was performed on a subset of these cytokines to characterize the 
temporal expression of pro-inflammatory cytokines and smooth or rough 
Brucella infection (FIG. 20).  Proinflammatory cytokines responded as expected 
for gram-negative bacteria.  In general, there was increased expression of pro-
inflammatory cytokines in mice infected with smooth Brucella melitensis.  The 
difference between parental smooth strains and constructed rough strains was 
apparent from the outset, particularly in MIP1α.  TNFα showed a somewhat 
delayed increase, but still quite profoundly different between the two strains.  
TNFα levels peaked early, by four hours, and then began a gradual decline, 
which is characteristic of this cytokine (121).  MIP1α and IL12 show a gradual 
peak over the 72-hour timeframe, while IL1α seems to show a gradual increase 
for smooth strains.  There is sudden, early peak in IL1α for mice infected with 
rough strains, which quickly declines at later time points. 
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FIG. 19. Induction of different cytokine and chemokine responses by Brucella melitensis 
16M wild type and the deletion mutant Brucella melitensis 16M∆manBA::KmR.An antibody-based 
array containing specific antibodies for 32 different cytokines/chemokines was used to determine 
differences in expression of cytokines/chemokines in mice infected with smooth or rough 
bacteria.  Samples applied to the blots were pooled ascitic fluid of mice over the entire 7-day 
time course.  Key differences were seen between the pro-inflammatory cytokines, IL6, IL12, 
IFNγ, MIP2, and TNFα as well as differences in levels of the chemokines, KC, MCP1, and 
TIMP1. 
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FIG. 20. Increased levels of pro-inflammatory cytokines from mice infected with smooth 
bacteria.  Sera were taken from mice infected with 108 smooth or rough bacteria.  Cytokine 
concentration was determined by sandwich ELISA, as described in the Materials & Methods.  
Smooth Brucella consistently induces higher levels of proinflammatory cytokines.  The bimodal 
distribution apparent with levels of TNFα and IL1α is probably due to circulation of resident 
phagocytic cells from the initial site of infection, to the peripheral blood and recruitment of 
peripheral phagocytic cells to the peritoneum.  Data are the average of pooled samples from 
duplicate experiments ± standard deviation. 
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DISCUSSION 
In this study, invasion and survival phenotypes of rough Brucella mutants 
were investigated in macrophage and mouse models of brucellosis.  Brucella 
has two predominant host cell types that it inhabits in vivo, macrophages and 
trophoblasts (123).  The macrophage appears to be the primary residence of 
Brucella in experimental hosts (45), while in pregnant animals the trophoblast 
has been shown to play host to Brucella (36).  This study shows that lack of LPS 
does not permit Brucella to recruit the correct cell type to establish infection. 
First, macrophage-like cell lines were used to characterize the survival 
phenotype of smooth Brucella melitensis and an isogenic manBA knockout.  
Knocking out the manBA operon has been shown to ablate LPS biosynthesis, 
with the resultant immunological consequences being reduced survival in serum 
mediated killing assays, macrophages, and the host model (4, 5, 50, 53).  Rough 
mutants were found to have impaired survival, but possibly only as result of the 
death of the host cell.  This cytotoxic phenomenon was observed over 40 years 
ago by Freeman et al. (54), and has only been recently rediscovered (50, 112).  
Death of the host cell in this experimental system would expose the bacterium to 
gentamicin in the media, killing the bacteria.  In vitro, the reduction of rough 
Brucellae by macrophages, although significant, is not very great. 
Rough mutants were also found to have increased uptake at early time points 
in the macrophage and acute mouse model, by an unknown mechanism.  
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Fernandez-Prada et al. showed that Brucella rough mutants have increased 
affinity for serum complement (50) (49).  Enhanced uptake due to complement 
may play a role in increased uptake in vivo.  Presence of serum complement is 
one of the key differences between the in vivo mouse model and in vitro 
macrophage model.  This phenomena needs to be investigated more carefully, 
as characterization of uptake differences between smooth and rough bacteria 
may help elucidate immunological responses to virulent organism.  
In an acute model of disease, differences in cellular recruitment were evident 
by differential cellular analysis.  Smooth Brucella recruited macrophages to the 
site of infection, while rough Brucella recruited larger numbers of neutrophils.  
This dichotomy in cellular recruitment is most likely the root of decreased 
survival of rough Brucella.  Generally, neutrophils exhibit much greater killing 
ability compared to macrophages, though Brucella has evolved some defense 
mechanisms to prevent neutrophil degranulation (95).  One of these defenses is 
LPS; increased killing of rough Brucella by neutrophils has previously been 
demonstrated (87).  Other aspects of Brucella’s defense against neutrophils 
include the secretion of GMP and adenine (95).   
These differences in cellular recruitment were borne out by observations from 
an antibody based array assessing the chemokines and cytokines present 
during the course of infection.  On the array, pro-inflammatory cytokines were 
up-regulated in mice infected with smooth strains, while a basal level of 
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expression was apparent on the array treated with ascitic fluid from mice 
infected with rough Brucella.  However, the real difference between these arrays 
was in the up-regulation of neutrophil specific chemokines. 
In rough Brucella infected mice, there is increased expression of TIMP-1 and 
the mouse CXCL1 chemokine, KC. TIMP-1 degrades basement membrane, 
promoting infiltration of inflammatory cells (25).  The presence of KC is indicative 
of neutrophil influx.  In fact, in murine models of anthrax, KC has been shown to 
cause influx of neutrophils, followed by neutrophil mediated killing of bacteria 
(113).  Differences in cellular recruitment probably account for differences in the 
cytokine and chemokine profile measured by ELISA, as the proinflammatory 
cytokines measured in this experiment are primarily secreted by macrophages. 
Modifications to the bacterial cell surface would most certainly change the 
way the host perceives Brucella.  Current insights into innate immunity suggest 
that the primary receptor for gram negative LPS is TLR-4 mediated (10, 75).  In 
the past six months, data has shown temporal involvement of TLR-2 then TLR-4 
in the stimulation of innate immunity by gram-negative pathogens (141).  Indeed, 
CHO cells transfected with TLR-2 and TLR-4 show a response to the presence 
of both smooth and rough LPSs from Brucella.  However, rough LPS alone is 
insufficient to stimulate TLR-4 (21). 
Brucella LPS plays an important role in acquisition of the host environment.  
LPS is protective against macrophage killing, complement mediated killing and 
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reactive nitrogen and oxygen intermediates.  More importantly, it appears to play 
a role in recruitment of the ‘correct’ cellular partner to advance brucellosis from 
an acute infection to a chronic infection. 
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CONCLUSIONS AND FUTURE WORK 
 
Lipopolysaccharide is the major component of Gram-negative cell walls and 
as a result, is an active participant during the early stages of host agent 
interaction.  O-antigen is the immunodominant antigen on the Brucella surface 
and as a result, the serological response is dominated by antibody to O-antigen.  
This body of work has demonstrated that the metabolic locus, manBA, 
participates in the synthesis of O-antigen.  The manBA locus is subject to higher 
than expected mutation rates, and is a substantial participant in the phase-
variant nature of pathogenic Brucella melitensis and Brucella abortus strains.  
Further, manBA may be subject to regulation by a trans-acting factor, pleD. 
The role of O-antigen in acquisition of the host was tested using macrophage 
and mouse models.  In both mice and macrophages, rough bacteria are more 
readily taken up.  Contradictory to indications from the macrophage model, 
smooth strains of Brucella stimulated more proinflammatory cytokine activity in 
the mouse.  Smooth LPS appears to be important in recruiting macrophages to 
the site of infection, in contrast to the neutrophils recruited by rough strains, to 
effectively colonize the host.  This data adds credence to the adage that LPS 
plays an important role in the intracellular trafficking of Brucella (52, 64, 121), 
although not in a traditional role of protecting the bacterium from physical effects 
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of host killing mechanisms.  Rather, the role of Brucella LPS as a signaling 
molecule needs to be explored. 
Signaling through toll-like receptors needs to be studied in more detail.  The 
deep rough strains presented in this work are ideal for carrying these signaling 
studies forward, since unlike RB51, they make no lipopolysaccharide (28).  From 
the literature, there are implications that the toll-like receptors are important for 
processivity of Brucella (21, 43, 76).  Toll-like receptors are pattern recognition 
receptors, and as such have been shown to have affinities for particular 
Pathogen Associated Molecular Patterns (PAMPs).  For gram-negative bacteria, 
the essential PAMPs are lipids and LPS.  Lipids activate macrophages through 
TLR2 and LPS activates macrophages through TLR4.  So far, studies 
investigating Brucella and TLR’s are limited in scope and have concentrated on 
cementing the link between TLR4 and Brucella LPS, rather than focusing on 
TLR mediated signaling in the presence of live bacteria.  Campos et al. have 
taken the first look at live Brucella in a mouse model, and present cytokine data 
is contradictory to the accepted paradigm from macrophage models, though it 
agrees with the data presented here.  The disjoint between macrophage derived 
data and data from animal models is a dangerous pitfall, and displays the 
limitations of both systems. 
Experimental Salmonella infections have been shown to include temporal 
involvement of both TLR4 and TLR2 (141).  Toll-like receptors are expressed at 
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low level on resting macrophages (140).  Upon activation, TLR4 is expression 
down-regulated early (6 hours), while TLR2 expression comes up gradually (by 
24 hours).  In this particular line of experimentation, the early involvement of 
TLR4 is largely responsible for control of the bacterium.  TLR4 knockout mice 
did not produce the same inflammatory response as TLR4 competent mice, 
though both TLR4 and TLR2 were necessary to clear the infection.  The roles of 
TLR4 and 2 could be investigated for Brucella infections using similar 
techniques.  Rough Brucellae should be unable to signal through the TLR4 
mediated pathway.  This may be the source of the decreased cytokine 
production by the rough mutant in the mouse, despite profound activation in 
vitro. 
The dynamics of Brucella LPS expression, as a line of investigation, have 
been opened up by the current study.  Regulation of LPS expression/phase is 
the next logical step.  A clear link between the appearance of rough forms and 
dissociation has yet to be established; fluorescence microscopy appears to be 
the tool of choice to make these observations with antibody specific to smooth 
LPS.  Already, from the signature-tagged mutagenesis bank, it appears a 
candidate gene, the transcriptional regulator, pleD, has been found.  Loss of 
function at pleD resulted in a rough phenotype that was complemented in trans 
by manBA.  LPS control by a transcriptional network has huge implications for 
the virulence model.  Fluorescence microscopy assays can be put to work 
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immediately to look at dissociation inside host cells.  Currently, transcriptional 
regulation of LPS biosynthesis in Brucella is “black box”.  In other species, 
dissociation is an integral component of virulence.  
With the advent of microarray technologies, picking apart the LPS 
biosynthesis pathway may become more feasible.  For instance, Vibrio cholerae 
has both smooth and rugose forms.  Rugosity actually has been found to confer 
an advantage to Vibrio in the environment (120).  In 2004, Yildiz et al. used 
microarray analysis and determined that there are significant changes in 
bacterial transcriptional networks, beyond the scope of the predicted LPS 
biosynthesis genes. 
Lipopolysaccharide plays an important role in the pathogenesis of 
brucellosis.  This study has established the central role of a metabolic locus in 
the formation of LPS and the importance of LPS for acquisition of the host.  
Further questions to be asked include the regulation of LPS biosynthesis in 
Brucella as well as the importance of Brucella LPS as a signaling molecule. 
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APPENDIX A 
 
A-1 Exact sequence of manBA amplified from Brucella melitensis 
 
 
                                     25                         50 
            TTCCAGGCAG ATACAGGTTC GATGGCAGCA TGAGCAGCAA TTCCCTCAAA 
            AAGGTCCGTC TATGTCCAAG CTACCGTCGT ACTCGTCGTT AAGGGAGTTT 
 
                                     75                        100 
            TTTGGCACGA GCGGCCTTCG CGGGCTGGCG GTAGAACTGA ACGGCCTGCC 
            AAACCGTGCT CGCCGGAAGC GCCCGACCGC CATCTTGACT TGCCGGACGG 
 
                                    125                        150 
            CGCCTATGCC TATACGATGG CCTTTGTGCA GATGCTTGCT GCAAAAGGGC 
            GCGGATACGG ATATGCTACC GGAAACACGT CTACGAACGA CGTTTTCCCG 
 
                                    175                        200 
            AGTTGCAGAA GGGCGACAAG GTGTTTGTCG GCAGGGATTT GCGCCCCTCC 
            TCAACGTCTT CCCGCTGTTC CACAAACAGC CGTCCCTAAA CGCGGGGAGG 
 
                                    225                        250 
            AGCCCTGATA TTGCAGCCCT TGCCATGGGT GCCATCGAAG ATGCCGGCTT 
            TCGGGACTAT AACGTCGGGA ACGGTACCCA CGGTAGCTTC TACGGCCGAA 
 
                                    275                        300 
            CACACCGGTC AATTGCGGCG TCCTGCCCAC GCCTGCGCTG AGCTATTATG 
            GTGTGGCCAG TTAACGCCGC AGGACGGGTG CGGACGCGAC TCGATAATAC 
 
                                    325                        350 
            CGATGGGCGC GAAAGCACCC AGCATCATGG TCACGGGAAG CCATATTCCA 
            GCTACCCGCG CTTTCGTGGG TCGTAGTACC AGTGCCCTTC GGTATAAGGT 
 
                                    375                        400 
            GATGATCGCA ACGGGCTGAA ATTCTATCGC CGCGACGGTG AAATCGACAA 
            CTACTAGCGT TGCCCGACTT TAAGATAGCG GCGCTGCCAC TTTAGCTGTT 
 
                                    425                        450 
            GGATGATGAG GCGGCAATCA GTGCAGCCTA TCGCAAGCTG CCTGCCATTC 
            CCTACTACTC CGCCGTTAGT CACGTCGGAT AGCGTTCGAC GGACGGTAAG 
 
                                    475                        500 
            TCGCTGCCCG CAAACATGTC GGCTCCACCG AAACCGATGC GGCCTTGCAG 
            AGCGACGGGC GTTTGTACAG CCGAGGTGGC TTTGGCTACG CCGGAACGTC 
 
                                    525                        550 
            GCTTATGCCG ATCGCTATGC AGGTTTTCTT GGGAAAGGGA GCCTGAATGG 
            CGAATACGGC TAGCGATACG TCCAAAAGAA CCCTTTCCCT CGGACTTACC 
 
                                    575                        600 
            CCTGCGGGTC GGCGTTTATC AACATTCTTC CGTGGCGCGC GATCTTCTGA 
            GGACGCCCAG CCGCAAATAG TTGTAAGAAG GCACCGCGCG CTAGAAGACT 
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                                    625                        650 
            TGTACCTGCT CACGACACTC GGCGTGGAAC CCGTGGCGCT CGGACGATCC 
            ACATGGACGA GTGCTGTGAG CCGCACCTTG GGCACCGCGA GCCTGCTAGG 
 
                                    675                        700 
            GATATATTCG TGCCGGTCGA TACCGAGGCA TTGCGCCCCG AAGACATTGC 
            CTATATAAGC ACGGCCAGCT ATGGCTCCGT AACGCGGGGC TTCTGTAACG 
 
                                    725                        750 
            GCTGCTTGCC CAATGGGGCA AAAGCGACAG GCTTGATGCC ATCGTCTCCA 
            CGACGAACGG GTTACCCCGT TTTCGCTGTC CGAACTACGG TAGCAGAGGT 
 
                                    775                        800 
            CCGACGGAGA CGCGGATCGC CCGCTGATTG CCGATGAGCA TGGACAATTC 
            GGCTGCCTCT GCGCCTAGCG GGCGACTAAC GGCTACTCGT ACCTGTTAAG 
 
                                    825                        850 
            GTTCGCGGCG ATCTTGCTGG CGCCATCACC GCCACATGGG TGGGGGCGGA 
            CAAGCGCCGC TAGAACGACC GCGGTAGTGG CGGTGTACCC ACCCCCGCCT 
 
                                    875                        900 
            TACGCTCGTC ACGCCAGTCA CCTCCAACAC CGCATTGGAA AGCCGCTTTC 
            ATGCGAGCAG TGCGGTCAGT GGAGGTTGTG GCGTAACCTT TCGGCGAAAG 
 
                                    925                        950 
            CCAAGGTTTT GAGAACGCGC GTCGGTTCGC CTTATGTCAT CGCAAGCATG 
            GGTTCCAAAA CTCTTGCGCG CAGCCAAGCG GAATACAGTA GCGTTCGTAC 
 
                                    975                       1000 
            GCACAGGTAT CCACGGGCAA TTCCGGCCCG GTCATCGGGT TTGAGGCCAA 
            CGTGTCCATA GGTGCCCGTT AAGGCCGGGC CAGTAGCCCA AACTCCGGTT 
 
                                   1025                       1050 
            TGGCGGCGTT CTGCTTGGCA GCACGGTCGA GAGGAATGGA CGAAGCCTGA 
            ACCGCCGCAA GACGAACCGT CGTGCCAGCT CTCCTTACCT GCTTCGGACT 
 
                                   1075                       1100 
            CGGCCCTGCC GACGCGCGAC GCCTTGTTGC CCATTCTGGC TTGCCTTGCC 
            GCCGGGACGG CTGCGCGCTG CGGAACAACG GGTAAGACCG AACGGAACGG 
 
                                   1125                       1150 
            ACGGTTCACG AAAAGAAAAC GCCGCTTTCA ACAATCGCCC GGTCCTATGG 
            TGCCAAGTGC TTTTCTTTTG CGGCGAAAGT TGTTAGCGGG CCAGGATACC 
 
                                   1175                       1200 
            CTTCCGCGTC GCGCTTAGCG ACCGGCTGCA AAACATTCCG CAGGAGGCGA 
            GAAGGCGCAG CGCGAATCGC TGGCCGACGT TTTGTAAGGC GTCCTCCGCT 
 
                                   1225                       1250 
            GCACCGCCTT CCTCGCGCTC TTGGAGGATG CGGATAAACG CGCCTCGCTC 
            CGTGGCGGAA GGAGCGCGAG AACCTCCTAC GCCTATTTGC GCGGAGCGAG 
 
                                   1275                       1300 
            TTTCCTGCTG GCGACGCAAT CGTGCGGGTG GAAACCATCG ACGGCGTGAA 
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            AAAGGACGAC CGCTGCGTTA GCACGCCCAC CTTTGGTAGC TGCCGCACTT 
 
                                   1325                       1350 
            GCTTTTCTTT CAATCAGGCA ATGCGGTTCA TTATCGGGCA TCGGGCAATG 
            CGAAAAGAAA GTTAGTCCGT TACGCCAAGT AATAGCCCGT AGCCCGTTAC 
 
                                   1375                       1400 
            CGCCGGAACT GCGCTGCTAT GTGGAATCTT CGGATGACAC ACAAGCCGCC 
            GCGGCCTTGA CGCGACGATA CACCTTAGAA GCCTACTGTG TGTTCGGCGG 
 
                                   1425                       1450 
            AAGCTTCAGG CGCTTGGCTT GGAAATCGCA CGCAAAGCAC TAAAGGATGC 
            TTCGAAGTCC GCGAACCGAA CCTTTAGCGT GCGTTTCGTG ATTTCCTACG 
 
                                   1475                       1500 
            GACGAGGCCA TGAGTTTCAT ACCGGTAATT ATCAGCGGGG GATCGGGTTC 
            CTGCTCCGGT ACTCAAAGTA TGGCCATTAA TAGTCGCCCC CTAGCCCAAG 
 
                                   1525                       1550 
            AAGGCTTTGG CCGCTTTCGC GGGATGCACA TCCAAAACCC TTTATCAAAC 
            TTCCGAAACC GGCGAAAGCG CCCTACGTGT AGGTTTTGGG AAATAGTTTG 
 
                                   1575                       1600 
            TGCCGGATGG CGAAACACTC ATCGGCAAGA CCTATGCGCG CGCTTCGCGC 
            ACGGCCTACC GCTTTGTGAG TAGCCGTTCT GGATACGCGC GCGAAGCGCG 
 
                                   1625                       1650 
            CTTGTAAACG CCGAACAGAT CCTTACGGTT ACGAACCGCG ATTTTCTTTT 
            GAACATTTGC GGCTTGTCTA GGAATGCCAA TGCTTGGCGC TAAAAGAAAA 
 
                                   1675                       1700 
            CCTGACGCTC GACGCTTATG CGGCGGCAGG TGCCGCGCAG ATGGAAAACA 
            GGACTGCGAG CTGCGAATAC GCCGCCGTCC ACGGCGCGTC TACCTTTTGT 
 
                                   1725                       1750 
            CTTTCCTTCT GGAGCCGCTT GGCCGCGACA CCGCGCCCGC AGTGGCGCTT 
            GAAAGGAAGA CCTCGGCGAA CCGGCGCTGT GGCGCGGGCG TCACCGCGAA 
 
                                   1775                       1800 
            GCCGCCCTTC ATGCCGCTGA AGCCTATGGG CCGGATGCCA CGCTTCTGGT 
            CGGCGGGAAG TACGGCGACT TCGGATACCC GGCCTACGGT GCGAAGACCA 
 
                                   1825                       1850 
            CATGCCGGCC GATCACCTGA TCGAGGATGA ACAAGCCTTC GCGGAAGCGG 
            GTACGGCCGG CTAGTGGACT AGCTCCTACT TGTTCGGAAG CGCCTTCGCC 
 
                                   1875                       1900 
            TTGCGAAAGC GCGCGCGCTT GCCGAGGCAG GGCGCATCGT CACCTTCGGC 
            AACGCTTTCG CGCGCGCGAA CGGCTCCGTC CCGCGTAGCA GTGGAAGCCG 
 
                                   1925                       1950 
            ATTGTGCCGG ATCGGCCCGA GACCGGCTTC GGCTATATCG AAGTGCAAGG 
            TAACACGGCC TAGCCGGGCT CTGGCCGAAG CCGATATAGC TTCACGTTCC 
 
                                   1975                       2000 
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            TACGGATGTT CAGCGATTTG TCGAAAAGCC GGATGAGGCC ACCGCCCAGA 
            ATGCCTACAA GTCGCTAAAC AGCTTTTCGG CCTACTCCGG TGGCGGGTCT 
 
                                   2025                       2050 
            CCTATGTGGA AAGCGGACGC TATTTCTGGA ATTCCGGCAT GTTCTGCTTC 
            GGATACACCT TTCGCCTGCG ATAAAGACCT TAAGGCCGTA CAAGACGAAG 
 
                                   2075                       2100 
            AAGGCATTGA GCATGATCGA CGCCATGCAG CGTTACGCAC CGCAGGTACT 
            TTCCGTAACT CGTACTAGCT GCGGTACGTC GCAATGCGTG GCGTCCATGA 
 
                                   2125                       2150 
            GGCAGGCGCT AGGGCTGCCC TCGCCCAGGC CCGGCGTGGC AATAACGGCG 
            CCGTCCGCGA TCCCGACGGG AGCGGGTCCG GGCCGCACCG TTATTGCCGC 
 
                                   2175                       2200 
            AGACCAAAAC CCTTGAAATC GCCAGGGACG AGTTTGCCGC AACGCCTGCC 
            TCTGGTTTTG GGAACTTTAG CGGTCCCTGC TCAAACGGCG TTGCGGACGG 
 
                                   2225                       2250 
            ATTTCCATCG ACTACGCAGT CATGGAAAAG GCGGACAATA TGGCCTGCGT 
            TAAAGGTAGC TGATGCGTCA GTACCTTTTC CGCCTGTTAT ACCGGACGCA 
 
                                   2275                       2300 
            GCCCGTTTCC TGCGGCTGGT CGGATATCGG CTCATGGGCG GCGATGGCCG 
            CGGGCAAAGG ACGCCGACCA GCCTATAGCC GAGTACCCGC CGCTACCGGC 
 
                                   2325                       2350 
            ATCTCGTGAC ACCCGATGAA AACGGCAATC GCCTGCGCGG AGAAACTGTT 
            TAGAGCACTG TGGGCTACTT TTGCCGTTAG CGGACGCGCC TCTTTGACAA 
 
                                   2375                       2400 
            CTGGAAGATA CGACCAACAG TTTCGTCCTT TCTGAAACCC GTCTGGTGAG 
            GACCTTCTAT GCTGGTTGTC AAAGCAGGAA AGACTTTGGG CAGACCACTC 
 
                                   2425                       2450 
            CCTTGTCGGT GTGCATGATC TTCTCGTGGT TGACACGCCG GACGCCCTTC 
            GGAACAGCCA CACGTACTAG AAGAGCACCA ACTGTGCGGC CTGCGGGAAG 
 
                                   2475                       2500 
            TCGTCGCTCA TCGCGACAAA GCGCAGGAAG TACGCAGCGT TTTCAACAAA 
            AGCAGCGAGT AGCGCTGTTT CGCGTCCTTC ATGCGTCGCA AAAGTTGTTT 
 
                                   2525                       2550 
            TTGCGCAAGC AAGGTCATGA AGCTGCAAAG CTGCACCGCA CAGCCCATCG 
            AACGCGTTCG TTCCAGTACT TCGACGTTTC GACGTGGCGT GTCGGGTAGC 
 
                                   2575                       2600 
            CCCATGGGGC ACCTATACCG TGCTGGAAGA GGGCGACGGC TTCAAGATCA 
            GGGTACCCCG TGGATATGGC ACGACCTTCT CCCGCTGCCG AAGTTCTAGT 
 
                                   2625                       2650 
            AACGGATCGA GGTAAAGCCA GGGCGGCGCC TCAGCCTTCA GGCCCATCAC 
            TTGCCTAGCT CCATTTCGGT CCCGCCGCGG AGTCGGAAGT CCGGGTAGTG 
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                                   2675                       2700 
            CACCGCTCCG AACACTGGAT CGTGGTGTCC GGCACGGCAA AGGTGACGAA 
            GTGGCGAGGC TTGTGACCTA GCACCACAGG CCGTGCCGTT TCCACTGCTT 
 
                                   2725                       2750 
            TGGCGACCGG GAAATCCTGC TCACCACCAA TCAGTCAACC TATATTCCCT 
            ACCGCTGGCC CTTTAGGACG AGTGGTGGTT AGTCAGTTGG ATATAAGGGA 
 
                                   2775                       2800 
            GCGGTTTCCG CCACCGGTTG GAAAATCCCG GTATTTTGCC CCTCGTCCTG 
            CGCCAAAGGC GGTGGCCAAC CTTTTAGGGC CATAAAACGG GGAGCAGGAC 
 
                                   2825                       2850 
            ATCGAGGTGC AGAGCGGCGA ATATCTCGGT GAAGACGACA TCGTGCGCTA 
            TAGCTCCACG TCTCGCCGCT TATAGAGCCA CTTCTGCTGT AGCACGCGAT 
 
                                   2875                       2900 
            TGACGATGTT TACGGACGCG TTTGAAACAT ATTCAGCCAA ATGCGAACCG 
            ACTGCTACAA ATGCCTGCGC AAACTTTGTA TAAGTCGGTT TACGCTTGGC 
 
                                   2925 
            GCTTTGGCAT TCGGCCTATT GGGAT 
            CGAAACCGTA AGCCGGATAA CCCTA 
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